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SUMMARY  
 Advanced information technologies promise a massive influx of individual-specific med-
ical data. These rich sources offer great potential for an increased understanding of disease mech-
anisms and for providing evidence-based and personalized clinical decision support. However, 
the size, complexity, and biases of the data pose new challenges, which make it difficult to trans-
form the data to useful and actionable knowledge using conventional statistical analysis. The so-
called “Big Data” era has created an emerging and urgent need for scalable, computer-based data 
mining methods that can turn data into useful, personalized decision support knowledge in a flex-
ible, cost-effective, and productive way.  
 The goal of my Ph.D. research is to address some key challenges in current clinical deci-
sion support, including (1) the lack of a flexible, evidence-based, and personalized data mining 
tool, (2) the need for interactive interfaces and visualization to deliver the decision support 
knowledge in an accurate and effective way, (3) the ability to generate temporal rules based on 
patient-centric chronological events, and (4) the need for quantitative and progressive clinical 
predictions to investigate the causality of targeted clinical outcomes. The problem statement of 
this dissertation is that the size, complexity, and biases of the current clinical data make it very 
difficult for current informatics technologies to extract individual-specific knowledge for clinical 
decision support. This dissertation addresses these challenges with four overall specific aims:  
 Evidence-Based and Personalized Decision Support: To develop clinical decision support 
systems that can generate evidence-based rules based on personalized clinical conditions. The 
systems should also show flexibility by using data from different clinical settings.  
Interactive Knowledge Delivery: To develop an interactive graphical user interface that 
expedites the delivery of discovered decision support knowledge and to propose a new visualiza-
tion technique to improve the accuracy and efficiency of knowledge search.  
  xiii 
Temporal Knowledge Discovery: To improve conventional rule mining techniques for 
the discovery of relationships among temporal clinical events and to use case-based reasoning to 
evaluate the quality of discovered rules.  
Clinical Casual Analysis: To expand temporal rules with casual and time-after-cause 
analyses to provide progressive clinical prognostications without prediction time constraints.  
 The research of this dissertation was conducted with frequent collaboration with Chil-
dren’s Healthcare of Atlanta, Emory Hospital, and Georgia Institute of Technology. It resulted in 
the development and adoption of concrete application deliverables in different medical settings, 
including: the neuroARM system in pediatric neuropsychology, the PHARM system in predictive 
health, and the icuARM, icuARM-II, and icuARM-KM systems in intensive care. The case studies 
for the evaluation of these systems and the discovered knowledge demonstrate the scope of this 
research and its potential for future evidence-based and personalized clinical decision support.
 
	  
  1 
	  
CHAPTER I 
1 INTRODUCTION  
 This chapter introduces the motivation for the research and four grand challenges to cur-
rent healthcare informatics: evidence-based and personalized clinical decision support, interactive 
knowledge delivery, temporal knowledge discovery, and clinical casual analysis. No single re-
searcher has had a significant impact on all of these grand challenges, but I present how these 
problems shaped the development of the four specific aims of this dissertation. 
1.1 Current Clinical Decision Support 
 According to the National Health Statistics Group, US health expenditure had reached 
$3.1 trillion in 2013, which is over ten times the level of 1980. As shown in Figure 1.1.1a, The 
expenditure per year is estimated to reach $5.5 trillion within the following decade [1]; this is 
about 21 percent of total economic output (GDP) [2]. US citizens currently pay about twice as 
much per capita (>$8,000 USD) on healthcare as our peers do in other advanced nations (Figure 
1.1.1b) [3]; however, our health outcomes are not better. To improve the quality of care while 
lowering its cost, healthcare experts, policymakers, payers, and consumers have made tremen-
dous investments in health information technology, such as electronic health records and comput-
erized provider order entry [4, 5]. Among these information technologies, data mining has been 
drawing enormous attention and provides many future opportunities [6]. 
	    





(b)                                                                       
Figure 1.1.1 Statistics of US Healthcare Expenditure 
(a) The projected National Health Expenditures from 2013 to 2023 
Figure source: http://www.commonwealthfund.org/publications/fund-
reports/2013/jan/confronting-costs 
(b) Average Healthcare Spending per Capita 
Figure source: http://stats.oecd.org/ 
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 Data mining is a relatively new concept that emerged in 1990s as a new approach to data 
analysis and knowledge discovery. In 2001, a technical review published by Massachusetts Insti-
tute of Technology identified data mining as one of the ten emerging technologies that would 
change the world [7], and, after a decade, we have begun to appreciate its impact. One of the most 
widely-used definitions states that “data mining is the analysis of (often large) observational data 
sets to find unsuspected relationships and to summarize the data in novel ways that are both un-
derstandable and useful to the data owner” [8]. Therefore, the goal of data mining is to transform 
data from large datasets into useful information and new knowledge so as to make correct deci-
sions and take appropriate actions. In the current Big Data era, data mining in healthcare has the 
particular potential to leverage the growing availability of digital medical data and reduce the 
time gap between that data availability and support of final actionable decisions derived from the 
data [9]. 
 The viability of data mining has been proven by its successful application in biomedical 
and clinical research, which provides novel knowledge for clinical practice (e.g., treatment selec-
tion, investigation of diagnosis, and prognosis prediction) and administrative purposes (e.g., re-
source estimates, insurance, and quality of care assurance) [10-14]. Broadly speaking, the process 
of data mining reflects the transition of data to knowledge (illustrated in Figure	  1.1.2) and it starts 
in healthcare with a mostly unstructured large clinical data warehouse (often accumulated for op-
erational purposes). Given a target clinical research problem, researchers extract a portion of the 
data from the warehouse and transform the data into a structured and analyzable dataset. The 
main task is to define a methodology to build models that can translate the raw data into human-
readable knowledge. If the knowledge is novel, valid, and effective after rigid clinical evaluation, 
researchers can distribute the knowledge in reports or publications for the use of the provider 
community.  
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Figure 1.1.2 Conventional Data Mining Process from Medical Data to Knowledge 
 
 The last step of medical knowledge discovery is to apply the knowledge (obtained using 
data mining techniques) to make final clinical decisions and take appropriate action in real medi-
cal practice. In conventional medical practice, care providers (e.g., physicians, nurse practitioners, 
or physician assistants) have internalized knowledge bases reflecting published literature and de-
rived experience relevant to their medical expertise.  As illustrated in Figure 1.1.3, when a patient 
seeks help from a health care provider (i.e., a medical encounter), the provider first accesses the 
patient’s medical record, acquires information about symptoms or diseases, and performs physi-
cal examination and tests to correlate with these clinical signs. Based on all available information 
and necessity, the provider must then make a proper diagnosis and order appropriate treatment 
based on their assessment of the expected course of a disease (i.e., prognosis). If decisions cannot 
be confidently made, the provider may need to search and extract relevant decision support 
knowledge from a knowledge base. The provider has to interpret the extracted knowledge by 
cross-referring with all available information and medical guidelines so as to make the appropri-
ate decision and ultimately take the correct action. However, this kind of process makes the final 
decision rely not only on a clinician’s empirical knowledge and experience but also on subjective 
human biases and inherent uncertainty [15].   
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Figure 1.1.3 Conventional Approach of Adopting Knowledge in Clinical Decision and Ac-
tion 
   
 Increasingly modern, advanced data acquisition technologies can provide a massive in-
flux of clinical person-centered data, which grants providers the possibility to provide a more in-
dividualized (i.e., customized) clinical decision. However, due to the limitations of human intel-
lectual abilities [16] and conventional statistical analysis [17], it is very challenging to transform 
such voluminous, complex, and biased clinical data into patient-specific decisions; particularly in 
the time-sensitive manner often required. Therefore, even in the current Big Data era, the practi-
cal ability to use real actual actionable knowledge remains limited. This creates the need for com-
puterized data mining techniques to realize a truly evidence-based and personalized clinical deci-
sion support system [18]. 
1.2 The Four Grand Challenges of Current Clinical Decision Support 
 Data mining technology has been much slower to impact the medical community than 
other communities in research and in industry. There are very good reasons for this delay. First, it 
is difficult to adopt conventional decision support models to customize patient-specific clinical 
characterization. Second, there are only a few systems with interactive interfaces that can accu-
rately and effectively deliver clinical decision support knowledge. Third, current models only 
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consider data collected at a specific time point in a clinical encounter (e.g., the time of admission), 
ignoring the temporal changes in patient conditions. Finally, conventional decision support mod-
els only provide single and static references for overall clinical outcome (e.g., one score for the 
overall mortality), instead of providing progressive prognostications with continuous references. 
These four challenges contribute to the problem statement of this dissertation. The following sec-
tions discuss them in more detail. 
1.2.1  Evidence-Based and Personalized Decision Support 
 Evidence-based medicine is the “conscientious, explicit and judicious use of current best 
evidence in making decisions about the care of individual patients.” [19] A clinical decision sup-
port system is evidence-based if its knowledge base is derived from, and continually reflects, the 
most up-to-date evidence from the scientific literature and practice-based sources [20]. Develop-
ing evidence-based decision support models is one of the major purposes of clinical knowledge 
discovery [21]. Models with significant validations and refinements became widely used illness 
scoring systems, such as Acute Physiology and Chronic Health Evaluation (APACHE) [22] and 
Simplified Acute Physiology Score (SAPS) [23]. Despite being viewed as important tools in 
medical practice, it is still challenging to apply these models to provide personalized decision 
support with patient-specific information collected in current Big Data era [24].  
 The development of a conventional decision support model starts with a target clinical 
problem to be solved (e.g., mortality and prolonged ICU stay). Researchers then select a set of 
attributes and apply feature selection methods to extract determinant ones. Finally, researchers 
apply data-mining techniques to construct models followed by appropriate validations. The goal 
of the process is to use as few attributes as possible to achieve acceptable decision-support accu-
racy. Such processes are abundant in the clinical data mining literature. However, conventional 
scales calculate scores via a set of fixed variables that can only apply to pre-determined “global” 
conditions. It is difficult to select the relevant model(s) to assess the risk of developing potential 
conditions based on an individual’s specific clinical conditions [25]. In addition, since conven-
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tional models have been developed and validated on cohort-based data, the feasibility of adjusting 
the result for individual situations is critical for decision making but has not yet been studied. For 
instance, the APACHE-III model consists of basic patient demographics, chronic health status, 
and 17 physiologic variables including vital signs, laboratory tests, and neurological conditions. 
These 17 variables are chosen to represent the hundreds of additional patient data elements that 
modern bedside monitoring technologies are actually capturing. Clinicians have to refer to the 
estimated risk score and adjust the final prognostication with many out-of-model conditions. The 
final decision still depends not only on a clinician’s empirical knowledge and experience but also 
on subjective human biases with inherent uncertainty [15]. 
 In order to obtain patient-specific decision support at the point-of-care, it is necessary for 
providers to interpret the information in the context of that patient. Such personalized medicine 
represents the customization of healthcare for each patient [26, 27]. Even though studies have 
suggested the potential of such models to offer more reliable patient-specific predictions than 
those offered by other, more general heuristics [28], studies that develop decision support models 
based on personalized clinical characteristics remain very rare in the literature.  
1.2.2 Interactive Knowledge Delivery 
 A true evidence-based clinical decision support system needs to be interactive. A majori-
ty of existing clinical decision support systems only provide the “statistics” of evidence. It is dif-
ficult for clinicians to make a correct decision by recalling all corresponding knowledge in a 
timely fashion. They may need to search their archives, find the appropriate literature, and inter-
pret relevant evidence and statistics (assuming it is up-to-date). However, such a decision support 
process is not feasible in modern healthcare settings, especially in the critical care setting where 
the luxury of time rarely exists, or in other clinical environments where physicians have increas-
ingly less time for each patient encounter. Thus, a reliable clinical decision support system should 
provide not only statistically significant knowledge but also an interactive user interface that al-
lows clinicians to effectively search for evidence with real-time clinical utility.   
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 Visualization analytics is the process facilitated by interactive visual and graphical inter-
faces so as to reduce the load on working memory, offload cognition, and harnesses the power of 
human perception [29]. In healthcare, visualization has been used to enhance the delivery of 
knowledge mined from complex and large clinical datasets. Healthcare information systems can 
generate a massive amount of data that can be navigated and represented visually in near-real 
time by the use of visualization techniques. Current healthcare applications of visualization can 
be categorized into one of the three groups of analyses [30]: business purposes [31], clinical oper-
ations (e.g. blood bank utilization), or scientific research in various health care-related fields, 
such as genomics [32], immunology [33], and epidemiology [34]. However, these visualization 
techniques were only designed to provide an overview of data or knowledge after analysis. It is 
still challenging to apply these visualization techniques to search for patient-specific knowledge.  
As I discussed in the first challenge, more and more personalized decision support knowledge can 
be generated using the output from current advanced technologies for the collection of individual-
specific data. However, there is a need for visualization techniques that allow providers to per-
form accurate and effective searches for patient-specific decision support knowledge, no matter 
how large the data size. 
1.2.3 Temporal Knowledge Discovery 
 Conventional clinical decision support models use values acquired in a fixed time period 
in a clinical encounter. For instance, Zygun et al. used data in the first 24 hours after admission to 
predict ICU mortality [35]. However, models with fixed observation periods may ignore the 
chronological progression of a patient’s conditions. For example, a patient’s hematocrit on ICU 
day three is likely to be different from that on the admission day but can be potentially just as or 
even more relevant. In addition, many models consider only the most abnormal values without 
accounting for the magnitude of change. For example, many models would treat a patient with a 
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clinical level that is five times mildly abnormal the same as another patient with a level this is 
barely outside the normal range, even though this difference may have real clinical implications. 
 In addition to the fixed observation time window, conventional decision support models 
provide scores as overall risk indicators for the entire clinical encounter, especially in the envi-
ronment of critical care. For example, the study in [36] uses the APACHE-III scale to generate a 
score for the prediction of mortality. Similarly, the Pediatric Index of Mortality (PIM) score pre-
dicts a pediatric patient’s overall likelihood of mortality based on data captured in the first few 
hours of ICU admission [37].  However, an “admission” score may not account for the changes in 
mortality risk that may be manifest in a progressively temporal manner or at different time points. 
Thus it is difficult to adopt an APACHE-III score to assess a patient’s mortality specifically at 48-
hr, 72-hr, or any time point after the admission. Even though we know the patient might have a 
high overall mortality, we may not be able to know when that specific time point is at which their 
clinical condition will deteriorate. Several studies provide decision support models for days other 
than the day of admission; however, no clear discrimination was found in comparison to those 
models for use only on the admission day [38].  
 Current information technologies allow clinical data to be chronologically collected 
throughout a medical encounter, e.g., data collected by bedside monitors. Here the time dimen-
sion is crucial, meaning that the focus is not only on the observed values, not only in the com-
posed sequence, but it is also very important that typical time that elapses between two clinical 
episodes. Furthermore, temporal changes may actually be as predictive as the admission data. For 
example, changes in neonatal heart rate variability may predict ensuing infections. Many clinical 
decision support models and systems ignore characteristics that constantly change with time. 
Therefore, there is a need for temporal knowledge-mining frameworks to uncover the essence of 
clinical episode evolution. 
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1.2.4 Clinical Casual Analysis 
 Many hypotheses generated using data mining techniques can be spurious and do not 
always reflect the true casuality between two clinical events. Thus, the process of knowledge 
generation cannot be called ‘causal’ analysis if the knowledge cannot imply the relation between 
an antecedent (the cause) and a consequent (the effect), where the effect is understood as a 
physical consequence of the cause. This means that mined knowledge may not have practical 
meaning if it is not verified by human knowledge. With the development of reliable mining 
processes for finding clinical causality, the determination of real causes, given a target outcome, 
has become a focus. 
 Casual relationships imply “the real data generation mechanisms and how the outcome 
would be affected when the cause is changed” [39]. The gold standard for conventional casual 
analysis remains ramdomized control trials (RCTs). However, a RCT is infeasible in personalized 
knowledge mining because the data collected in the trial may not be applicable to an individual’s 
specific characteristics (as discussed in the first challenge) and these trials can be prohibitively 
expensive. In addition, due to the high dimensionality of clinical data, applying conventional 
statistical analysis for casual analysis becomes difficult. Casual analysis has been applied in 
clinical knowledge discovery, such as the assessment of whether the relationship of serum 
homocysteine concentration with ischaemic heart disease, deep vein thrombosis, and stroke is 
causal and, if so, to quantify the effect of homocysteine reduction in preventing them [40]. 
However, applying casual analysis in personalized clinical decision support is rare even though 
the obtained knowledge can provide potential indicators for casual relationships [41].   
1.3 Proposed Study and Organization of Dissertation 
 This dissertation addresses the challenges mentioned above by applying advanced data 
mining techniques toward evidence-based and personalized, interactive, temporal, and progres-
sive clinical decision support. The four overall specific aims of this research were:  
  11 
(1) Evidence-Based and Personalized Decision Support: To develop analytic systems that use 
patient-specific clinical information to predict individual-tailored risks,  
(2) Interactive Knowledge Delivery: To develop an interactive visualization that enables ef-
fective search of personalized decision support knowledge,  
(3) Temporal Knowledge Discovery: To extend the personalized analysis framework (from 
the first aim) to incorporate temporal conditions over the course of a medical encounter,  
(4) Casual Analysis: To combine causal and time-after-cause analyses for progressive and 
continuous clinical risk prediction. 
 These four specific aims lay out three main versions of a technical data-mining frame-
work for facilitating necessary steps in the development of evidence-based and personalized clin-
ical decision support systems. Chapter 2 of this dissertation introduces the first version of the sys-
tem with a core of association rule mining to address the component of Evidence-Based and Per-
sonalized Decision Support. Chapter 3 addresses the Interactive Knowledge Delivery solution by 
developing an interactive visualization for effective search of association rules. Chapter 4 dis-
cusses the second version of the system that transforms the first version’s non-temporal frame-
work to a temporal mining framework by introducing the concept of the case-based mining, 
which provides the solution to Temporal Knowledge Discovery. This chapter also proposes a new 
rule selection strategy that provides better calibrated risk prediction compared with conventional 
strategy. Chapter 5 further advances the system (i.e., version three) by incorporating causal and 
time-after-cause analyses for the solution to Clinical Casual Analysis. Each version of the system 
is also embedded with interactive user interfaces that partially cover the solution to Interactive 
Knowledge Delivery.  
 Each chapter covers background and significance, gives a technical explanation of the 
system design, and presents results and documentation of the concrete deliverable. Figure 1.3.1 
summarizes the chapters, specific aims, proposed solutions, developed systems, and the corre-
sponding clinical settings. Each version of the system represents a combination of factors, but is 
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presented in the chapter that is most relevant. Finally, Chapter 6 concludes this dissertation by 
summarizing key deliverables of innovation, application, and publication, with future impacts. 
My research and the systems’ development were based on intensive collaborations with Emory 
Hospital and Children’s Healthcare of Atlanta (CHOA), which also demonstrates its viability in a 
variety of medical settings. It is expected that this research will be applied to future directions for 
evidence-based and personalized clinical decision support at Georgia Tech, Emory, CHOA, and 
in the wider community. 
 
Figure 1.3.1 Workflow of Dissertation Research 
This dissertation consists of four main chapters covering four main specific aims. Chapter 2 for 
Evidence-Based and Personalized Decision Support, Chapter 3 for Interactive Knowledge Deliv-
ery, Chapter 4 for Temporal Knowledge Discovery, and Chapter 5 for Clinical Causal Analysis. 
Each chapter is associated with one (two in Chapter 3) proposed solution. One or more systems 
were developed in each aim using different clinical data. Chapter 2 has three systems: neuroARM 
for pediatric neuropsychology study, PHARM for predictive health study, and icuARM for adult 
ICU study. Chapter 3 has one visualization algorithm, InterVisAR. Chapter 4 and Chapter 5 have 
the second version, icuARM-II, and the third version, icuARM-KM, of the ICU decision support 
system. Both of them were developed using pediatric ICU databases imported from Children’s 
Healthcare of Atlanta.  
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CHAPTER II	  
2 EVIDENCE-BASED PERSONALIZED CLINICAL DECISION SUPPORT 
USING ASSOCIATION RULES 
2.1 Introduction 
 The first objective of this dissertation was to develop a system that can generate associa-
tion rules for evidence-based and personalized clinical decision support. As illustrated in Figure 
2.1.1, the system is embedded with interactive graphical interface, allowing providers to input 
patient medical conditions-of-interest and retrieve the corresponding association rules. The sys-
tem can demonstrate its scalability to handle different sizes of data collected in different clinical 
settings. Association rule mining is the core of the mining framework, which is introduced in the 
first part of this chapter. Then three new rule interestingness metrics are presented for different 
clinical knowledge interpretations. Afterwards, the design of the system user interface is present-
ed. The system was evaluated in three different clinical case studies, including decision supports 
in pediatric neuropsychology (neuroARM), predictive health (PHARM), and the intensive care 
(icuARM) with data sizes from small, medium, to large. The background, data description, and 
result of each study are discussed based on their original publications in [42-44]. The summary is 
provided in the last part of this chapter with key accomplishments and innovations.  
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Figure 2.1.1 Flow of Using Association Rules for Personalized Clinical Decision Support 
2.2 Principle of ARM in Healthcare 
 Association rule mining (ARM) is a method to discover meaningful relations between 
variables in databases. Agrawal et al. [45] first introduces the concept of ARM to extract regulari-
ties between products in large-scale warehouse databases. Association rules are in the form of 
X⇒Y, which means that X implies Y, where X and Y are called antecedent and consequent [46]. X 
and Y can consist of one or more variables, meaning that the associations are not necessarily one-
to-one. Figure 2.1.1 illustrates an association rule using a Venn diagram. In its original marketing 
analysis, the rule X⇒Y carries the semantic that if a customer buys items in X, he/she is also like-
ly to buy items in Y. Such rules provide valuable knowledge in the decision about marketing 
strategies, such as promotional pricing and product placement  
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 Figure 2.2.1 Illurstration of an association Rule X⇒Y using Venn diagram 
 
 Two important metrics —support and confidence— quantify the frequency and level of 
association of a rule. I modified these two metrics from their conventional forms to fit the data in 
clinical settings [47]. First, the support of an association rule is defined as:  
 
where X ∪Y  indicates data tuples in which both X and Y occur; and XV ≠  and YV ≠  indicate 
data tuples in which all variables in X and Y have no missing values. For example, if X = 
“HeartRateMax > 80”, XV ≠  refers to data tuples in which HeartRateMax have been assigned 
values (i.e., no missing data). count(a) returns the number of tuples that contain a, where a can 
consist of one or more items. The numerator of (2.1) counts the total number of tuples that con-
tain all items in X∪Y. The denominator of (2.1) counts the total number of tuples that have no 
missing data in all variables of X and Y. This is critical in clinical data mining because its data is 
usually recorded when the patient is presenting a specific condition or undergoing a specific 
treatment. Focusing on clinical records that do not have any missing data in any of the variables 
of X and Y helps extract patients who are under similar clinical conditions. Therefore, the support 
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of a rule X⇒Y, ranging from 0% to 100%, indicates the fraction of database that hold both X and 
Y to those that have no missing data in all of the variables of X and Y. A high support for an asso-
ciation rule indicates that a high portion of database is applicable to the rule.  
 Another metric of an association rule is its confidence: 
 
For tuples that have no missing value in variables of X and Y, the confidence calculates the ratio 
(ranges from 0% to 100%) of tuples that match items in both X and Y to the records that match 
items values in X no matter the value of Y. For example, if the confidence of an association rule 
{HeartRateMax > 190} ⇒ {Death = YES} is 90%, it implies that for tuples that have 
{HeartRateMax > 190}, 90% of these stays have {Death = YES}. In other words, confidence re-
veals the level of the association between X and Y. 
 In order to discover frequent and confident association rules, the mining process requires 
users to specify two minimum values as thresholds to drop infrequent and unconfident rules, 
which are minimum support (Suppmin) and minimum confidence (Confmin). Rules are considered 
to be frequent if their supports are at least Suppmin and confident if their confidences are at least 
Confmin. The goal of ARM is to find all frequent and confident rules based on these two user-
specified values.  
 There are two main steps in discovering association rules. The first step is to find fre-
quent itemsets that have supports above Suppmin. The second step is to use the frequent itemsets to 
generate confident rules with confidences above the Confmin. Because the second step is straight-
forward, most of the research focus is on the first step. Since the first algorithm was introduced in 
the original report of ARM [45], new algorithms have been proposed to improve the efficiency of 
the generation of frequent itemsets. Among these algorithms, the Apriori algorithm is the most 
popular in ARM applications.  
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 The Apriori algorithm utilizes an iterative process to generate frequent itemsets.  Let I = 
{I1, I2, …, IN} consist of N possible items in the database. In the first iteration, the algorithm starts 
by counting the occurrence of 1-itemset candidates that contain only one item. 1-itemset candi-
dates that have supports lower than Suppmin are pruned out and the remaining ones are called fre-
quent 1-itemsets. In the following iterations (i.e., k>1), the candidate k-itemsets are first generated 
by joining the frequent (k-1)-itemsets. Then frequent k-itemsets are generated by pruning out can-
didate k-itemsets that have supports lower than Suppmin. The iteration continues until no more 
candidates or frequent itemsets can be found. The pseudo-code of the Apriori algorithm presented 
in [47] is given as follows:  
Algorithm: F = Apriori(T, I, Suppmin) 
// Input: T (Transactions), I (1-itemsets), Suppmin 
// Output: F (Frequent Itemsets) 
F1 = {f | f ∈ I, f.support ≥ Suppmin}; 
for (k = 2; Fk-1 ≠ ∅; k++) do 
  Ck = GenCandidate(Fk-1); 
  for each transaction t ∈ T do  
       for each candidate c ∈ Ck do    
    if c is contained in t then    
     c.count++;  
   end  
  end  
Fk = {c ∈ Ck | c.support ≥ Suppmin}  
end   
                                       return F = ∪k Fk; 
The GenCandidate in the Apriori algorithm is the candidate itemset generation algorithm that is 
given as follows:  
Algorithm: Ck = GenCandidate (Fk-1) 
// Input: Fk-1 (Frequent k-1 itemsets) 
// Output: Ck (Candidate k itemsets) 
Ck = ∅; 
forall fm, fn ∈ Fk-1 
     where fm = {i1, … , ik-2, ik-1} 
     and fn = {i1, … , ik-2, i’k-1} 
     and ik-1 ≠ i’k-1 do   
      c = {i1, …, ik-1, i’k-1}; 
    Ck = Ck ∪ {c}; 
   foreach (k-1)-subset s of c do  
   if (s ∉  Fk-1) then   
        delete c from Ck; 
      end 
end 
return Ck; 
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 After generating frequent itemsets via the Apriori algorithm, the second subproblem is to 
generate confident rules that satisfy Confmin. For each frequent itemset f, consider all non-empty 
subsets of f. For each subset a, the process forms a new rule a ⇒ (f-a) if its confidence is above 
Confmin. Then a and (f–a) can be called antecedent and consequent, which are the X and Y, respec-
tively, of an association rule.  
2.2.1  Importance, Dominance, and Effect of Association Rules  
 As described previously in (2.2), we can assess if a rule X⇒Y has a high level of associa-
tion according by its confidence. However, a high confidence of rule X⇒Y still cannot guarantee 
a low confidence of its counter case ( ). During clinical decision support, the mining pro-
cess should consider when the rule X⇒Y yields a higher confidence than its antecedent’s counter 
case (i.e., ). This means that Y is likely to occur only when X occurs. When X does not oc-
cur, Y has a low chance of occurrence. The following equation can be used to calculate the im-
portance of a rule X⇒Y:   
 
The importance metric ranges from 0 to ∞. Value of 1 is an important threshold for the im-
portance metric. A rule with importance < 1 means that the antecedent predicts the consequent 
worse than the counter case of the antecedent. This type of rule should be ignored. Thus the rules 
are expected to have an importance > 1. To avoid the rules with importance close to 1 (i.e., 0.9 
and 1.1) due to random chance, a more strict and higher threshold for importance can be selected 
to ensure statistical significance.   
 The three aforementioned metrics determine if a rule X⇒Y is frequent, confident, and 
important. However, a given consequent Y may be associated with different antecedents from dif-
ferent rules. For example, if X1 and X2 are both possible antecedents that associate with a conse-
quent Y, the mining process should emphasizes X1 if the presence of Y is dominated by X1. There-
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fore, a new metric was developed to determine the dominance of an antecedent on a rule’s conse-
quent. 
 
Similar to (2.2), a dominance value ranges from 0% to 100%. The dominance of a rule X⇒Y is 
identical to the confidence of Y⇒X because the rule can be viewed as the ratio of database that 
match items in X and Y to the records that match items in Y no matter the value of X. 
 So far the discussed metrics are all rule-wise, meaning that they are for the evaluation of 
rules. Because the antecedent of a rule can consist of multiple items, we may also need a new 
metric to determine how a new item affects a rule’s confidence value when we include the item in 
the rule’s original antecedent (i.e., X∪INew⇒Y). Evaluating effects of new clinical items would be 
helpful, for example, in making decisions about medication or treatment combinations. Addition-
ally, it is not necessary to always pursue items with positive or negative effects. Both positive and 
negative effects should be considered, depending on the clinical situation. For example, when the 
consequent of a rule is mortality, clinicians may not only perform treatments that may decrease 
the mortality, but also to avoid those that may increase the mortality.  




An effect value ranges between -1 and 1. Unlike the support, confidence, importance, and domi-
nance that are all rule-wise metrics, effect is an item-wise metric. 
2.3 Advantages and Applications of ARM in Healthcare 
 Using ARM in clinical decision support systems has four main advantages. First, unlike 
conventional statistical analysis that only indicates whether the relationship significant or not (e.g., 
using p-value), ARM gives each rule a confidence value that determines its strength more quanti-
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tively. Second, a rule is composed of an antecedent and a consequent that provide a direction of 
the relationship. Third, the antecedent and consequent can consist of one or more factors, provid-
ing advanced knowledge of complex factor interactions instead of monotonic relationship (e.g., 
logistic regression) [48]. Finally, ARM accepts user-specified inputs, which ensure the interest-
ingness of each rule to optimize the mining results.  
 ARM has been widely utilized in healthcare paradigm, such as heart disease prediction, 
healthcare auditing, and neurological diagnosis. For heart disease prediction, Konias et al. present 
an uncertainly rule generator (URG) that discovers rules for home-care monitoring of congestive 
heart failure patients [49]. Ordonez et al. adopt ARM in medical data and proposes an improved 
algorithm to constrain rules so as to speed up the mining process [50]. Auditing abusive and 
fraudulent healthcare behavior is another important application of ARM.  Shan et al. use ARM to 
examine billing patterns within a particular specialist group to detect suspicious claims and poten-
tially fraudulent individuals [51]. Bellazzi et al. introduce temporal ARM in the context of an au-
diting system to facilitate clinicians’ understanding of patients’ behavior and improve the quality 
of hemodialysis services [52]. ARM also draws attentions from neurology research. Authors in 
[53] propose a novel methodology for finding image-based association rules in functional single-
photon emission computed tomography (SPECT) image databases for early diagnosis of Alz-
heimer’s disease. Studies also have verified that ARM can find hidden diagnosis rules of devel-
opmentally-delayed children, so as to enable healthcare professionals in early intervention of de-
layed psychological developments [54].  
2.4 System Prototype User Interface 
A new system prototype was designed and developed specifically for evidence-based and 
personalized clinical decision support using ARM. The prototype features a user interface for re-
al-time usability. The interface enables the user to input real-time patient clinical scenarios, ex-
tract relevant confident association rules from the database, and display the rules. The system us-
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age flow is shown in Figure 2.4.1. As depicted, the ARM system consists of three main windows: 
(1) Rule Mining window, (2) Effect Browsing window, and (3) New Item window. The interface 
was implemented in MATLAB (MathWorks, Natick, MA). The user can freely switch among 
these three windows for different purposes.  
 
Figure 2.4.1 Workflow of ARM  
The system prototype consists of three main windows, including a Rule Mining window (A), an 
Effect Browsing window (B), and a New Item window (C). The Rule Mining window receives 
user inputs as Rule Control (dashed box). The system synchronizes with three sources, including 
the back-end database, Item Bank that stores all created items, and Rule Bank that stores all pre-
existing rules. 
The first main interface is the Rule Mining window (Figure 2.4.2) that enables the clini-
cians to extract association rules based on customized antecedents and consequents. The window 
accesses two data sources. The first data source of the system is the Rule Bank which stores rules 
that were previously mined. The second data source is the Item Bank that stores all pre-existing 
items. The mining process starts from constructing all items of interest in antecedents and conse-
quents. Based on these items, the system retrieves all possible raw rules from the Rule Bank 
based on Suppmin = 0% and Confmin = 0%. The user can apply several inputs to prune out infre-
quent and/or unconfident rules by increasing Suppmin and/or Confmin, respectively. Because ante-
cedents and consequents of the displayed rules may contain multiple items, the user can specify 
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the length (i.e., the number of items) of processed antecedents and/or consequents. In addition, 
the rules can be sorted by one of the four rule-wise metrics (i.e., support, confidence, importance, 
and dominance). Furthermore, the user can export all raw rules or processed rules in comma-
separated values (CSV) format, which can be exported into Microsoft Excel or other statistical 
analysis tools (e.g., SPSS) for future analysis. 
 
Figure 2.4.2 ARM System Interface - Rule Mining Window 
Users can construct antecedents and consequents of interest by selecting items in the Antecedent 
panel and the Consequent panel, respectively. The association rule results are displayed in the 
Association Rules panel. Users can manipulate rules by giving control inputs in the Rule Control 
panel. The control inputs include the type of Suppmin, maximum length of items in antecedents 
and consequents, Suppmin, Confmin, and the sorting type. Rules can be exported from the “File” 
menu. Users can access the New Item window and Effect Browsing window via the bottom two 
buttons. 
The second main window is the Effect Browsing window (Figure	  2.4.3) that enables the 
clinicians to browse item-wise effects after the rules are extracted from the Rule Bank. When giv-
en a target consequent, this interface starts by displaying all rules that contain only one item in 
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their antecedents with their corresponding four rule-wise metrics. Once a first-item has been se-
lected in the antecedent, the browser lists all possible second-items with their corresponding ef-
fects (i.e., the confidence changes). The browsing continues until no more potential items can be 
selected in the antecedent. 
 
Figure 2.4.3 ARM System Interface - Effect Browsing Window 
Users can browse the effects of possible items on the right. The antecedent with selected items is 
shown on the left with the current rule measures. Users can keep selecting possible items from the 
right until no more potential items are available. Users can return to the Rule Mining window by 
clicking the Mining button. 
The third main window is the New Item window (Figure	  2.4.4) that allows clinicians to 
create new items. As mentioned in the Rule Mining window, the user can select items to construct 
customized antecedents and consequents. However, the user may not always find items of interest 
that have been created in the system. Therefore, the New Item window allows the user to con-
struct new items by selecting a category, choosing a variable (i.e., the first component of the item) 
under the category, and assigning a value or a range of values (i.e., the second component of the 
item) to the variable. If the chosen variable is event-based, the user can also assign a value of 
mean, minimum, maximum, and standard deviation.  The user can also select the event duration if 
it is available. Once the user submits new items, the system stores them in the Item Bank, access-
es the database, and generates new rules. 
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Figure 2.4.4 ARM System Interface - New Item Window 
In the Create New Item panel, users can create new items by selecting a variable under a category 
and assigning a value or a range of values. The pending new items are listed in the New Items 
panel. By clicking the Submit button, the system stores the new items and generates all corre-
sponding rules. Users can browse all existing items in the All Items panel. Users can return to the 
Rule Mining window by clicking the Mining button. 
2.5 Three Case Studies of Newly Designed ARM System 
 The prototype was applied and evaluated in three different clinical case studies in three 
specific systems, including decision supports in pediatric neuropsychology (neuroARM), predic-
tive health (PHARM), and intensive care (icuARM) with data sizes from small, medium, to large. 
The background, data description, and result of each study are discussed in this sub-chapter based 
on their original publications in [42-44]. 
2.5.1 Pediatric Cerebral Palsy 
2.5.1.1 Background 
Cerebral Palsy (CP) is a non-progressive group of disorders of motor and posture caused 
by brain injury that may occur during the prenatal, perinatal, and/or postnatal period [55]. The 
  25 
prevalence of CP has remained stable over time and is estimated to occur in four out of 1,000 
births equally between males and females [56]. CP is the most common motor disability of child-
hood that often co-occurs with other medical morbidities. Evidence has shown that children with 
low birth weight (<1500 g) are at high risk for CP [57]. The underlying etiologies of CP vary, but 
a global cause of damage during the brain development is generally implicated.  
General symptoms of CP vary depending on type, severity, and limb involvement but 
may also include tremors, muscle weakness, rigidity, ataxia, gait abnormalities, and gross and 
fine motor difficulties. Additionally, there are many medical morbidities that can co-occur with 
CP, such as seizures, epileptic disorders, neurocognitive impairments, motor disability from hy-
drocephalus [58], mental retardation, impaired vision or hearing, and speech delay [59]. Although 
CP is considered to be a “static” disorder from a neurological standpoint, the physical symptoms 
or impairments may appear to change over-time as daily or functional tasks become more de-
manding [60]. 
Given the nature of CP and related motor impairments, psychological assessment can be 
a difficult task. For example, the motor impairments seen in children with CP can pose challenges 
with regard to reliable assessment of intellectual functioning, specifically on performance-based 
tasks. Therefore, neurocognitive tests that rely heavily on intact motor skills for adequate comple-
tion, but do not directly control for motor ability, are likely to be lower in this population. Alt-
hough literature suggests that histories of lower birth weight, use of antiepileptic drugs, or shunt 
placement may contribute to cognitive and motor difficulties, there has been a paucity of research 
trying to statistically predict what percentages of patients will incur cognitive, motor, and behav-
ioral problems as a result of CP. Therefore, in this case study, I applied the proposed ARM proto-
type, in a new system called neuroARM, through medical history and neuropsychological in-
strument scores of children diagnosed with CP. neuroARM was aimed to discovered meaningful 
relationships among age, birth weight, and cognitive, motor, and behavioral disorders so as to 
assist CP professionals to provide young children with accurate assessments and treatments.  
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2.5.1.2 Dataset 
The dataset used in neuroARM was collected from a sample of 155 patients that were 
seen in the clinical setting of Children’s Healthcare of Atlanta (CHOA). The study was approved 
by Institutional Review Board (IRB) from CHOA and Emory University before the data collec-
tion. Over a five-year course (2008-2012), these patient records were placed into a database after 
a retrospective chart review was completed. The data was compiled and evaluated for subjects 
that had testing on measures of intellect, visual-motor coordination, and neurobehavioral symp-
toms. Finally, the data was de-identified before being processed by neuroARM. 
 The 155 patients with CP were referred for an outpatient neuropsychological evaluation 
by their attending neurologist. Data of each patient consists of administrated demographic infor-
mation and medical data includes age, history of seizure (SeizureHx), shunt placement due to hy-
drocephalus (ShuntPresent), current antiepileptic drugs use (OnAEDs), and birth weight 
(BWGram). The mean age is 10 years old (range 5-20 years, SD = 3), 19% with history of shunt-
ed hydrocephalus, and 64% have low birth weight (BWGrams<2500g). 
 The following neuropsychological instruments were administered to the subjects in this 
study. 
 Intellectual Ability: To measure the intellectual ability, one of the following scale was 
selected based on age of the subject: Wechsler intelligence scale for children, 4th edition (WISC-
IV), Wechsler abbreviated scale of intelligence (WASI), Wechsler adult intelligence scale, 3rd 
edition (WAIS-III), and Wechsler preschool or primary scale of intelligence, 3rd edition (WPPSI-
III). A Full Scale IQ (FSIQ) score was finally calculated. 
 Visual Motor Ability: The Beery-Buktenica developmental test of visual-motor integra-
tion, 5th edition (VMI-5) scale was used to assess the extent to which patients can integrate their 
visual and motor abilities. 
  27 
 Neurobehavioral Function: Two neurobehavioral function scores are considered in the 
target mining attributes. First, behavior rating inventory of executive function – parent form and 
emotional subtest (BRIEFpEmo) scale was used to assess emotional disorders of the subjects. Se-
cond, behavioral assessment system for children, 2nd edition – patient rating scales and depres-
sion subtest (BASCpDep) scale was selected to evaluate depression symptoms.  
 Because not all of the patients have scores of all neuropsychological instruments, in order 
to increase supports of the generated rules, the dataset was split into two groups. Group 1 consists 
of 60 patients who have both FSIQ and VMI scores, but may have missing scores of BASCpDep 
and BRIEFpEmo. Group 2 has 71 patients who have both BASCpDep and BRIEFpEmo scores, 
but may have missing scores of FSIQ and VMI. Twenty-one patients have all four types of scores 
and belong to the two groups. 
2.5.1.3 Results and Discussion 
 neuroARM can generate association rules for the prediction of both normal and abnormal 
cognitive and motor difficulties, while this section only presents those that can predict abnormali-
ties because they deserve more attention.  
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Table 2.5.1 lists final 22 rules that can predict problematic consequents (e.g., FSIQ<80). These 
rules were analyzed by a domain expert (i.e., a neuropsychologist from CHOA) to ensure their 
clinical interestingness. The rules are classified according to their consequents, and rules in each 
group are ordered by confidence values. 
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2 OnAEDs=Yes 22 83 
3 ShuntPresent=Yes 12 70 
4 Age>=15 & SeizureHx=Yes 10 67 
5 OnAEDs=Yes & BRIEFpEmo>60 15 65 
6 ShuntPresent=Yes & SeizureHx=Yes 13 64 




9 OnAEDs=Yes & FSIQ<80 22 81 
10 ShuntPresent=Yes 14 81 
11 SeizureHx=Yes 34 80 
12 FSIQ<80 41 80 
13 SeizureHx=Yes & FSIQ<80 31 72 
14 ShuntPresent=Yes & BWGrams<2500 12 70 
15 Age>=15 & SeizureHx=Yes 10 67 
16 Age>=15 & BWGrams<2500 10 67 
17 OnAEDs=Yes 
FSIQ<80 & VMI<80 
22 81 
18 SeizureHx=Yes 31 72 
19 ShuntPresent=Yes 10 60 
20 OnAEDs=Yes BRIEFpEmo>60 17 71 21 OnAEDs=Yes & FSIQ<80 15 65 
22 BRIEFpEmo>60 BASCpDep>60 28 68 
Rules Predicting IQ Disability 
 History of seizure, use of AEDs, and shunt placement are all good predictors of lower IQ, 
and history of seizure predicts the best. Age is also a factor impacting a patient’s IQ when inter-
acting with the seizure history. According to rule #4, if an older adolescent has seizure history, 
his/her possibility of lower IQ is higher than children who also have seizure history but are 
younger. This rule confirms the implication that symptoms or impairments of CP may appear to 
change over-time, as daily or functional tasks become more demanding. In addition, a patient 
who is taking AEDs and with low emotional control, he/she may also develop low IQ. Finally, 
shunt placement may affect a patient’s IQ when it co-occurs with seizure history or low birth 
weight. 
Rules Predicting Visual Motor Deficits 
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 Similar to IQ, AED, shunt placement, and history of seizure are all good predictors of 
visual motor deficits among which AEDs is the best one. In addition, lower IQ can also imply 
lower visual-motor integration ability when it happens alone or co-occurs with use of AEDs or 
history of seizure. Besides, a patient who has a combination of lower birth weight and shunt 
placement history may also have 72% chance of visual-motor dysfunction although the birth 
weight itself cannot predict well. Finally, older adolescents with history of seizure or lower birth 
weight may also have lower VMI compared to those who have the same condition but are young-
er.  
Rules Predicting Emotional Disorder and Depression Symptoms   
 As stated in rules from #20 and #21, use of AEDs and its combination with low IQ are 
the only two antecedents that can predict emotional disorder. Surprisingly, none of, age, history 
of seizure, shunt placement, or birth weight can predict emotional disorder. Besides, the level of 
emotional disorder in children with CP can also predict their symptoms of depression, which is 
shown in rule 22. This rule also supports the finding in the literature [61]; however, the neu-
roARM system cannot find other interesting rules that can predict depression symptoms. 
2.5.1.4 Summary of Case Study 
 Although literature suggests evidences that may contribute the understanding of cogni-
tive, motor, and behavior difficulties in children diagnosed with cerebral palsy (CP), it is a diffi-
cult task to statistically predict what percentages of patients will incur the abnormalities given the 
nature of the disease. This case study presents one application of my ARM system, named neu-
roARM, using a small-scale medical data with neuropsychological test scores. The mined rules 
by neuroARM provide useful quantitative knowledge of patients who have comorbid diagnoses 
and their risk for neurobehavioral concerns, motor deficits, and lower overall cognitive potential. 
Several rules of one-on-one relationships confirm medical and literature knowledge with high 
accuracy, while other rules can predict complex and interesting factor interactions. 
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2.5.2 Predictive Health 
2.5.2.1 Background 
Health expenditures in the United States reached $2.7 trillion in 2011, over ten times the 
amount spent in 1980 [46], and the rate is still expected to grow faster than national income over 
the foreseeable future [62]. As over 90% of the medical spending is for patients with chronic dis-
eases [63], predictive health (PH) is a transformation towards maintaining health (rather then 
treating diseases) by proactively predicting health-related events and disease development, and 
providing early and persistent interventions before being clinically overt. 
Recognized as a pioneer in PH, the Center for Health Discovery and Well Being 
(CHDWB®) was established in 2008 as the major research component of a combined Emory Uni-
versity/Georgia Institute of Technology strategic initiative: the Predictive Health Institute [64]. 
The specific goal of the center is to redefine health in a holistic fashion by broadly integrating 
health-related disciplines (e.g., ethics and sociology) with traditional disciplines of medicine, 
public health, and nursing through basic and clinical biomedical research. The CHDWB serves as 
an engine to drive the new healthcare definition through the conduct of a prospective cohort study 
of predominantly healthy individuals. It establishes a horizontal (as opposed to the traditionally 
vertical) relationship between participants and health partners who are trained to provide infor-
mation and support for the participant. A health partner assists participants in completing surveys 
and other assessments, reviews and explains the health assessment report, helps in setting and 
achieving their health-related goals, and provides practical advice and moral support. 
Currently, health partners are trained using didactic and practical experiences in the 
knowledge base and skill set. To pursue systematic and objective health advising and planning, 
the CHDWB has started investigating computer-based decision support systems embedded with 
advanced data mining methods. However, three major factors make data mining in PH more chal-
lenging compared to typical disease-based data mining. First, because the definition of health de-
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pends on interacting factors that are not limited to biology, PH data must contain measurements 
from multiple disciplines to provide a comprehensive picture of human health. However, multi-
disciplinary data increases information heterogeneity among measurements, which poses a com-
mon challenge in data mining. Second, for PH data, measurements of some variables are highly 
homogeneous across the healthy cohort. It increases the difficulty of identifying accurate rules or 
effective separating boundaries for data given a measurement. Third, conventional data mining 
methods (e.g., support vector machine [65]) heavily depend on data distributions. A distribution-
free data mining method may be preferable while dealing with heterogeneous data. 
 To address the aforementioned three challenges, in this study I applied the proposed 
ARM prototype and constructed a new PH decision support system called Predictive Health As-
sociation Rule Mining (PHARM). PHARM is powered by a CHDWB dataset containing reports 
with 906 measurement variables from a large predominantly healthy cohort. The user interface 
allows users to perform flexible association rule mining to achieve personalized decision support 
for PH and CHDWB participants. 
2.5.2.2 Dataset 
	   Because	  most	  human	  diseases	  result	  from	  perturbations	  in	  common	  pathways	  involving	  
oxidative	  stress,	  inflammation,	  and	  regenerative	  potential,	  CHDWB	  incorporates	  cutting	  edge	  
biomarkers	  in	  these	  areas	  with	  established	  and	  novel	  assessments	  of	  health	  and	  healthy	  
behavior.	  Initiated	  in	  May	  2008,	  dataset	  in	  PHARM	  system	  contains	  2,637	  de-­‐identified	  health	  
reports	  from	  696	  healthy	  participants	  with	  906	  measurement	  variables.	  As	  tabulated	  in	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Table 2.5.2, each report consists of measurement outcomes, including questionnaires, assess-
ments, physical measurements, laboratory tests, and research laboratory values. Together, these 
measurements provide a comprehensive picture of human health, and the ability to discern and 
detect potential diseases. 
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Table 2.5.2 Examples of CHDWB Measurements 
Measurement Type Examples 
Questionnaires Demographics, personal and family health history, occupational his-tory and exposures, tobacco and alcohol usage. 
Assessments Perceived stress scale, block food frequency questionnaire, CAPS physical activity questionnaire, SF-36 (v2). 
Physical measure-
ments 
Resting blood pressure, resting heart rate, bioelectrical impedance 
analysis, dual-energy X-ray absorptiometry scan.  
Lab tests Lipid panel, blood chemistries, urine creatinine and microalbumin, vitamin B12, iron and total iron binding capacity. 
Research lab values Oxidized and reduced glutathione, cysteine, cystine, CysGSH, CysRedox, serum protein nitrotyrosine.  
 
2.5.2.3 Results and Discussion 
 Mental illness encompasses psychological patterns that disrupt an individual’s feelings, 
mood, thinking, daily functioning, and social ability. Survey-based scales are the most common 
tools to measure the severity of mental disorders. Literature of mental health scales mainly focus 
on development [66], validation [67], modification for specific populations [68], and comparison 
between scales [69]. However, to my best understanding, there is no research that tries to com-
prehensively find associations among these scales.  
 Because the development of mental illness can be related to a variety of psychological 
factors, the usability of PHARM was demonstrated by discovering association rules to predict 
mental illness based on scale scores of five psychological factors, including family functioning, 
social support, depressive symptoms, perceived empathic self-efficacy, and anxiety disorder. A 
summary score of each scale was used, and the mean and standard deviation (STD) of scores 
from 2,637 reports were calculated. Instead of using recommended cut-points provided by scales, 
cut-points for disorder ranges were statistically set to be the mean + STD if high scores imply 
disorders, otherwise, mean − STD. Table 2.5.3 provides a complete list of targeted psychological 
factors, scales, and disorder ranges. The mining Suppmin was set as 1.5% since mental disorders 
are relatively rare in the healthy population, especially for those who have compounded disorders. 
Such threshold for support implies that each rule was mined from at least 40 records (out of 2,637 
records). I set Confmin = 80% as suggested by domain experts, to ensure the confidence of each 
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rule. The final 12 rules are listed in Table 2.5.4. These rules can predict potential mental illness 
measured by general mental health group in SF-36.  
Table 2.5.3 PHARM Case Study - CHDWB Assessment Scales and Disorder Ranges 
Scale Disorder Range 
SF36M: Short Form (36) Survey Mental Health < 45.91 
FAD: Family Assessment Device > 2.37 
ESSI: ENRICHD Social Support Inventory < 23.95 
BDI: Beck Depression Inventory > 9.12 
PSSE: Perceived Empathic Self-Efficacy Scale > 25.41 
GAD7: Generalized Anxiety Disorder 7-item > 6.19 
 
Table 2.5.4 PHARM Case Study - Rules Predicting General Mental Problem 
Rule # Antecedent Support Confidence 
1 ESSI + BDI + PSSE + GAD7 1.6% 99.8% 
2 ESSI + BDI + PSSE  3.1% 93.4% 
3 BDI + PSSE + GAD7 + FAD 1.6% 93.8% 
4 ESSI + PSSE + GAD7 2.6% 92.6% 
5 ESSI + BDI + PSSE +FAD 1.6% 91.3% 
6 ESSI + BDI + GAD7 2.7% 89.5% 
7 BDI + PSSE + FAD  2.5% 88.1% 
8 ESSI + BDI + FAD 2.2% 86.6% 
9  BDI + GAD7 + FAD 4.1% 84.4% 
10 BDI + PSSE 6.8% 82.0% 
11 BDI + PSSE + GAD7 2.8% 82.1% 
12 BDI + FAD 5.5% 81.9% 
 4-factor 1.6% 95.0% 
Average 3-factor 2.9% 88.1% 
 2-factor 6.2% 82.0% 
 
 The mined rules in this study provide important knowledge to (1) prevent the develop-
ment of mental illness and (2) prioritize advice and action plans to reduce the risk of existing 
mental illness. According to Table 2.5.4, in general, rules with more antecedent items have lower 
support values because they represent more specific cases. On the other hand, specific cases tend 
to have higher confidence values. That is the reason why there is no confident rule with 1-item 
antecedent because people with only one psychological disorder are typically at low risk of men-
tal illness compared to those with compounded disorders. However, providers should pay more 
attention to prevent the development of compounded disorders even when a person is currently 
having only one psychological disorder. For example, if a person is currently having depressive 
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symptoms (BDI), we may want to provide proactive advice to prevent the development of disor-
ders especially in perceived empathic self-efficacy (PSSE, rule #10) and family functioning (FAD, 
rule #12) because they are associated with mental illness risk if comorbid with BDI. On the other 
hand, providers can also use these rules to prioritize the action plans to reduce the risk of existing 
mental illness. For instance, according to the rule #1, individuals who have compounded disor-
ders in social support (ESSI), depression (BDI), perceived empathic self-efficiency (PSSE), and 
anxiety (GAD7), are associated with the highest possibility (99.8%) of mental illness. Among 
these four factors, we should first focus and set action plans for disorders of social support (ESSI) 
because it can significantly (p=0.02 using χ2-test) drop the risk from 99.8% to 82.1% by compar-
ing rule #1 to rule #11.  
2.5.2.4 Summary of Case Study 
 In this study, I applied the ARM system and developed a interactive decision support sys-
tem, called PHARM, in the research of predictive health (PH). By leveraging a medium-scale PH 
dataset from 696 subjects, the rules mined by PHARM can be used for the discovery of personal-
ized health prediction knowledge. To demonstrate the usability, I utilized the system to investi-
gate association rules to predict mental illness based on five psychological factors. The results 
provide important knowledge to prevent the development of mental illness and prioritize advice 
and action plans to reduce the risk of worsening existing mental illness. 
2.5.3 Intensive Care Unit 
2.5.3.1 Background 
 The modern intensive care unit (ICU) typically has the highest mortality rate of any unit 
in a hospital. According to the Society of Critical Care Medicine (SCCM), there are approximate-
ly five million patients admitted annually to ICUs in the United States with average mortality 
rates ranging from 10% to 29% [45]. In addition, the ICU has some of the highest rates of medi-
cal errors, as compared to most clinical settings, due to the complexity of care [70, 71]. The mod-
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ern ICU, with high levels of body sensing and monitoring, generates a large volume of complex 
and multimodal data. Making critical clinical decisions from such heterogeneous multimodal data 
has become increasingly challenging. In other words, the data is richer, but the ability to integrate 
it remains difficult. Clinical decision support systems (CDSSs) are computer-aided “active 
knowledge systems which use two or more items of patient data to generate case-specific advice” 
[72]. Evidence has strongly suggested that CDSSs can improve a physician’s decision making 
performance [72]. In the ICU, the goal of CDSSs is to improve outcomes in critically ill patients 
by providing real-time decision support, decreasing medical errors, and minimizing life-
threatening events caused by delayed or uninformed medical decisions. For optimal medical deci-
sion making, the CDSS needs to be data-driven, rapid, and informed. 
 Evidence-based medicine is the “conscientious, explicit and judicious use of current best 
evidence in making decisions about the care of individual patients” [19]. A CDSS is evidence-
based if its knowledge base is derived from, and continually reflects, the most up-to-date evi-
dence from the scientific literature and practice-based sources [20]. A generic form of evidence in 
an evidence-based CDSS is the IF-THEN rule. The rule implies IF an antecedent (i.e., a set of 
conditions) presents, THEN an outcome is expected or an action should be taken. In the literature, 
evidence-based CDSSs have provided important risk assessment scores for clinicians, such as 
prediction of ICU survivability (e.g., APACHE II [22]), length of stay [73], organ failure (e.g., 
SOFA [74]), neurologic prognosis (e.g., Glasgow Coma Score [75]), and outcomes after acute 
coronary syndrome (e.g., GRACE ACS model [76]). However, none of the above applications are 
true CDSSs because they are not interactive or flexible, which are two key features of true deci-
sion support systems [77]. To my best knowledge, no true CDSSs have been developed for the 
ICU. 
 A true evidence-based ICU CDSS needs to be interactive. A majority of ICU systems that 
claim to be CDSSs only provide the “statistics” of evidence. It is difficult for clinicians to make a 
correct decision by recalling all corresponding knowledge in a timely fashion. They may need to 
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search their archives, find the appropriate literature, and interpret relevant evidence (assuming it 
is up-to-date). However, such a decision support process is not feasible in the critical care setting, 
as the luxury of time rarely exists in the ICU. Thus, a reliable CDSS should provide not only sta-
tistically significant knowledge but also an interactive user interface that enables clinicians to ef-
fectively search for evidence in real-time.  
 In addition to being interactive, an evidence-based ICU CDSS should be flexible. In typi-
cal ICU systems that claim to be CDSSs, researchers define expected IF-THEN rules (i.e., with 
conditions and outcomes or actions) given certain clinical problems, validate the rules (i.e., via 
human trial, lab experiment, or computer simulation), and form the new evidence if the rule is 
statistically significant (e.g., p<0.05). Afterwards, clinicians can refer to the evidence if the clini-
cal conditions are matched. For example, a clinician can select an appropriate antimicrobial drug 
for a septic patient when the pathogenic organism has specific hemodynamic and biochemical 
markers. However, some patients lack clear-cut evidence for the presence of an infection and/or 
the type of infecting organism, which makes the decision to treat with an antimicrobial drug expe-
rience-based instead of evidence-based. The clinician still needs to make the same decision about 
antimicrobial drug prescription with incomplete information, and then passively assess the prog-
nosis. Such a process introduces human bias that deviates from the original design of the CDSS. 
Clinicians face this challenge on a daily basis for every patient in the ICU due to heterogeneous 
conditions. Therefore, a flexible ICU CDSS is needed to allow clinicians to customize conditions 
to better describe a patient’s immediate status (i.e., personalized), instead of referring to fixed 
evidence formed from different clinical situations. 
 In addition to the two key features mentioned above, a powerful CDSS relies on a suffi-
cient and representative database of patient ICU stays. Although the bedside monitor can generate 
large amounts of data from each patient as compared to other care settings [78], clinicians are still 
limited by the actual number of unique patients in a standard ICU CDSS database. Clinicians 
cannot guarantee the accuracy of new decision support evidence if it is mined from a small set of 
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patients, because it will not reflect the diversity of phenotypes. In addition, even though some 
studies have large numbers of patients, the evidence was mined from the entire cohort without 
distinction. Ideally, before applying data modeling analysis, a CDSS should first automatically 
extract a cohort of patients who have similar medical histories, and situations then reveal the 
sample size as a reference when delivering new evidence back to clinicians. By doing so, clini-
cians can clearly understand if the evidence is mined from a sufficient and representative dataset.  
 To address the aforementioned challenges, in this study I adopted the proposed ARM 
prototype and developed a new ICU CDSS, called icuARM, using a large-scale database with 
more than 40,000 ICU stays of more than 30,000 adult patients. 
2.5.3.2 Database 
 The data in the icuARM is imported from the Multi-parameter Intelligent Monitoring in 
Intensive Care II (MIMIC-II) database. MIMIC-II is a publicly accessible ICU data repository 
containing records of over 40,000 ICU stays in which 32,000 are adult (>15 yrs) records and 
8,000 are neonatal (<2 yrs) records [79]. The data in MIMIC-II can be categorized into two major 
categories: clinical data and physiological data. The clinical data is collected from MIMIC-II’s 
ICU information systems and hospital electronic health record systems. The high-resolution phys-
iological data consists of time series waveforms and time series measurements from bedside mon-
itors. The data mining process in this study only includes clinical data.  
 The imported clinical data consists of approximately 232 million entries covering over 
13,000 variables. The MIMIC-II clinical data was further divided into two groups of categories: 
basic and event-based. The basic categories include data that remain unchanged during one ICU 
stay (e.g., patient demographics and pre-existing comorbidities). The event-based categories con-
tain data collected at multiple time points within an ICU stay, including laboratory tests (e.g., 
blood chemistries, complete blood counts), medication events (e.g., insulin, heparin), fluid bal-
ance (e.g., urine output), and nurse-verified chart measurements (e.g., blood pressure, heart rate). 
Values in event-based categories are processed to generate mean, minimum, maximum, and 
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standard deviation during an ICU stay. Durations of chart measurement, medication, and fluid 
balance events are also imported. The imported MIMIC-II clinical data is tabularized in Table 
2.5.5.  
Table 2.5.5 Description of MIMIC-II Clinical Data 





Number of ICU stays, stay sequence, first/last ICU day flag, stay in/out date, 
stay length (min), stay death flag, care unit of the first/last ICU day, SAPSI 
score, SOFA.  
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Demographics Gender, age, ethnicity, religion, date of birth/death, death flag, marital status, weight, height, admission type.  14 
Comorbidities 
Congestive heart failure, hypertension  cardiac arrhythmias, pulmonary circula-
tion, peripheral vascular, paralysis, neurological disorder, chronic pulmonary, 




1Medications Propofol, Insulin, Fentanyl, Heparin, Neosynephrine-k, Levophed-k, Midazo-lam, Lasix, Ativan, Labetolol, Integrelin.  406 
1Fluid balances Urine out fole, D10W, promote with fiber, urine, replete with fiber, lactated ringers, free water bolus, gastric nasogastric. 6,809 
Laboratory tests Hematocrit of blood, potassium in serum or plasma, creatinine in serum or plasma, urea nitrogen in serum or plasma, hemoglobin in blood, pH of blood.  714 
1Nurse-verified 
charting 
Heart rate, heart rhythm, blood pressure, noninvasive blood pressure, central 
venous pressure, SaO2, arterial PH, arterial PaCO2, arterial PaO2, arterial CO2, 
SpO2, respiratory rate.  
4,781 
1Event-based categories that include event duration 
 
2.5.3.3 Results and Discussion 
Pre-Existing Comorbidity vs. Prolonged ICU Stay 
 The length of stay (LOS) is a significant ICU outcome that is associated with severe or-
gan failure and high resource consumption [80, 81]. Evidence has shown that patients with pro-
longed (i.e., longer than 3 days) ICU stays have a considerably increased ICU, hospital, and long-
term mortality [82]. Patient comorbidity is a significant variable affecting the ICU LOS [83]. 
However, the survival is typically estimated on a long-term basis (e.g., 1-yr or 2-yrs survival) that 
is not applicable to the short-term ICU prediction. Therefore, in this case study, the icuARM was 
applied to generate association rules between pre-existing comorbidities and prolonged ICU stays.  
 Table 2.5.6 lists the four metrics of rules for 12 possible pre-existing comorbidities. The 
rule with hypothyroidism (HYP) as the comorbidity was ignored because its rule had importance 
less than 1. Congestive heart failure (CHF) had the highest support (8.6%), which means that this 
rule was applicable to the highest portion of the ICU stays. Additionally, according to the domi-
nance metric, CHF dominated the prolonged ICU stays by 22.4%, which was also the highest. 
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Table 2.5.6 icuARM Case Study - Preexisting Comorbidities vs. Prolonged ICU Stay 
Abbr. Comorbidity Supp (%) Conf (%) Impo Domi (%) 
COA Coagulopathy 2.8 54.1 1.4 7.4 
CHF Congestive Heart Failure 8.6 49.9 1.4 22.4 
CAA Cardiac arrhythmias 7.3 46.0 1.3 19.1 
REF Renal failure 2.4 44.6 1.2 6.3 
LID Liver disease 1.9 44.5 1.2 5.0 
OBE Obesity 0.6 43.0 1.1 2.4 
CHP Chronic pulmonary 5.6 41.5 1.1 14.8 
DEA Deficiency anemia 3.6 40.6 1.1 9.4 
DIA Diabetes 6.9 38.9 1.1 18.6 
CAN Cancer 4.5 37.1 1.0 12.2 
ABU Alcohol/drug abuse  2.0 36.9 1.0 5.3 
HYP Hypothyroidism 2.3 35.0 0.9* 6.0 
Supp, support; Conf, confidence; Impo, importance; Domi, dominance 
Confidence is the possibility of prolonged ICU stay. 
*Rule is ignored because the importance is less than 1. 
 In this case study, the possibility of prolonged ICU stay can be predicted by the confi-
dence of a rule given the comorbidities in the antecedent. According to the important rules (i.e., 
importance ≥ 1) shown in Table 2.5.6, coagulopathy (COA) is associated with the highest possi-
bility of prolonged ICU stay (54.1%), whereas alcohol/drug abuse (ABU) associated with the 
lowest possibility (36.9%). The association rules of the eight age-gender populations (i.e., age <2, 
15-30, 30-50, >50 years, and gender male and female) were also generated. Figure 2.5.1(a) shows 
that females aged over 50 had the highest possibility of prolonged ICU stay (38.8%), and males 
over 50 years had the second highest (38.2%). Interestingly, the pediatric population had the third 
and fourth highest possibility of prolonged ICU stay (female: 37.6%, male: 38.1%). This may be 
a reflection of the fact that most of the children within the MIMIC-II database are neonates in the 
neonatal ICU, where premature infants tend to have prolonged stays (up to months). 
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     (a)                                                                                                     (b) 
 
(c) 
Figure 2.5.1 icuARM Case Study - Rules of Comorbidities vs. Prolonged ICU Stays 
(a) Possibility of prolonged ICU stays in different age-gender populations. The three values of 
each bar are the three measures of the association rules, including support (top), importance 
(middle), and dominance (bottom). (b) The effects (i.e., changes in possibility of prolonged ICU 
stay) of the first-item comorbidities on prolonged ICU stay possibility in females aged over 50 
years. (c) The effects of the second-item comorbidities on prolonged ICU stay possibility in fe-
males aged over 50 years who also have coagulopathy.  
 The icuARM’s Effect Browsing window was used to investigate the effect of different 
combinations of pre-existing comorbidities in different populations on the possibility of pro-
longed ICU stay. I focused on females aged over 50 because of their highest possibility of pro-
longed ICU stay. Figure 2.5.1(b) shows all rules of the 11 first-item comorbidities in this popula-
tion. Coagulopathy (COA) was still associated with the highest possibility (58.6%) of prolonged 
ICU stay. In addition, females over 50 years who had alcohol and/or drug abuse showed an in-
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creased possibility (44.1%) even though this comorbidity did not have a high risk in the general 
population. 
 I continued investigating the effects (i.e., changes of possibility of prolonged ICU stay) of 
possible second-item comorbidities in females aged over 50 years who also had coagulopathy. As 
shown in Figure 2.5.1(c), there were 10 possible second-item comorbidities that were important 
(importance ≥ 1). Among them, six comorbidities increased the possibility, with deficiency ane-
mia (DEA) resulting in the highest rate of prolonged ICU stay (64.4%). Clinicians can continue 
the effect browsing process by adding other comorbidity combinations based on a patient’s status 
at admission. 
 After evaluating rules based on their support and confidence values, it is important to in-
terpret the importance value. Rules have lower importance values for more general cases with 
fewer items (in either the antecedent or consequent), and have higher importance values for more 
specific cases with more items. When comparing the importance values among Table 2.5.6 and 
Figure 2.5.1(a) to Figure 2.5.1(c), it can be observed that the importance values increase as more 
items are added to the antecedents. Therefore, even though theoretically it can go to infinity, in 
reality, it is more around 1.1-1.4. 
 In this case study, I have shown the basic usability of icuARM to assess associations be-
tween pre-existing comorbidities and prolonged ICU stays, especially in females aged over 50 
years. Clinicians can construct different combinations of age, gender, and pre-existing comorbidi-
ties to determine a baseline prolonged ICU stay possibility of a patient at the time of ICU admis-
sion, even prior to diagnosis. By estimating the possibility of prolonged ICU stay, an ICU team 
can efficiently plan ahead for the intensive care resource allocation such as staffing, laboratory, 
and radiology. This prediction also provides a risk reference to assess how certain interventions 
will affect LOS. For example, a clinician may admit two female patients of similar age. One has a 
coagulopathy (e.g., disseminated intravascular coagulation) and the other has an acute coronary 
syndrome. By using icuARM, the clinician and ICU team could accurately plan for needed re-
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sources for the former patient, predict outcomes, and improve management for this type of high 
risk ICU patient.  
Medication Usage vs. Prolonged ICU Stay 
 Mining associations between medication usage and clinical outcome is another promising 
application of icuARM. ARM has been adopted in several pharmacovigilance studies, such as 
investigating multi-item adverse drug reactions [84-86]. However, to my best knowledge, no 
CDSSs have adopted ARM for finding associations between medication usage and ICU outcomes. 
Therefore, in the second ICU case study, by using icuARM, I investigated the associations be-
tween prolonged ICU stays and medication usage in addition to patient demographics and pre-
existing comorbidities. 
 The icuARM system was first used to mine the association rules of two commonly used 
anti-hypertensive drugs in ICUs: diltiazem (DIL) and labetalol (LAB). Males and females over 50 
years were selected because they had the highest prolonged ICU possibility according to the pre-
vious case study. The associations on the drugs with a pre-existing comorbidity of congestive 
heart failure (CHF) were also investigated. As shown in Table 2.5.7, in patients over 50 years 
without CHF, DIL is associated with higher possibility compared to LAB in both females and 
males. However, these two drugs had different effects on patients with CHF. For females over 50 
years with CHF, the use of DIL increased the possibility of prolonged ICU stays to 83.4% com-
pared to females over 50 without CHF (73.6%), whereas LAB had nearly no change (62.3% vs. 
61.7%). In contrast, for the same clinical situation, the use of LAB actually increased the possibil-
ity in males over 50 years with CHF to 87.1% compared to those without CHF (62.8%), whereas 
DIL had almost no effect (74.7% vs. 76.0%). Therefore, for patients over 50 years with a comor-
bidity of CHF, clinicians may choose LAB for females and DIL for males.   
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Table 2.5.7 icuARM Case Study - Medication Usage vs. Prolonged ICU Stay (>50 
Years Old) 
 Probability of Prolonged ICU Stay (%) 
Comorbidity Gender LAB DIL EPI VAS EPI+VAS 
No CHF Female 62.3 73.6 67.6 64.7 67.6 Male 62.8 74.7 61.8 71.4 74.0 
Has CHF Female 61.7 83.4 84.5 82.0 84.2 Male 87.1 76.0 68.1 85.2 87.8 
CHF: congestive heart failure; LAB, labetolo; DIL, diltiazern;  
EPI, epinephrine; VAS: vasopressin 
 
 In addition to the hypertensive conditions, ICU clinicians often have a choice between 
pharmacologic agents in an acute episode of cardiopulmonary arrest. Epinephrine (EPI) and vas-
opressin (VAS) are two common drugs used in the management of ventricular fibrillation and 
pulseless electrical activity. icuARM was further applied to explore the associations between the-
se two drugs and prolonged ICU stays. In addition, Gueugniaud et al. suggested that combination 
of EPI and VAS did not improve outcome (i.e., survival to hospital discharge, good neurologic 
recovery, and 1-year survival) during advanced cardiac life support for out-of-hospital cardiac 
arrest [87]. However, evidence was still insufficient to make prognosis on short-term ICU stays. 
Therefore, by utilizing icuARM, the association between ICU LOS and a combination of EPI and 
VAS was also evaluated compared to EPI or VAS alone.  
 According to the result shown in Table 2.5.7, females over 50 years without CHF had 
slightly lower possibility of prolonged ICU stay with VAS compared to EPI (64.7% vs. 67.6%); 
in contrast, males over 50 without CHF had lower chance of prolonged ICU stay with EPI com-
pared to VAS (61.8% vs. 71.4%). These associations all increased on patients over 50 who also 
had CHF, but the EPI increased the possibility most on females (84.5%) compared to those with-
out CHF (67.6%). Furthermore, for the combination of EPI and VAS, the change of the possibil-
ity was not considerably different compared to EPI or VAS alone. This partially supported the 
finding of [87] although this case study focused on the short term ICU outcome. 
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 This case study demonstrated that icuARM could help guide the clinician to select correct 
medication for similar clinical situations but different patient populations in the pre-planning 
phase. The entire mining process requires no more than one minute, promising a nearly real-time 
and easy-to-access bedside consulting tool. 
2.5.3.4 Summary of Case Study 
 Evidence-based decision support for critically ill patients in the ICU has become more 
challenging because of the volume and complexity of the data. Thus, to assist clinicians in mak-
ing optimal decisions, there is a critical need to apply modern information technology and ad-
vanced data analytics to extract information from heterogeneous clinical data.  
 In this study, I adopted the proposed ARM prototype and developed a real-time clinical 
decision support system, called icuARM, to assist clinicians in generating quantitative and real-
time decision support rules for the ICU, based on an ICU database with a large patient population. 
The system adopted the “support” and the “confidence” metrics, which were suitable for ICU 
clinical application, from conventional association rule mining. In addition, the system included 
two rule-wise metrics (i.e., importance and dominance) and one item-wise metric (i.e., effect) for 
different clinical rule interpretations. icuARM had been tested in two case studies investigating 
the associations between prolonged ICU stays and patient demographics, pre-existing comorbidi-
ties, and medication usage. The results not only reinforced the current decision support evidence, 
but also revealed new knowledge by predicting characteristics of a prolonged ICU stay. 
2.6 Summary and Key Innovations 
 In this chapter, I have addressed the first specific aim of this dissertation by developing 
three systems that can generate association rules to provide evidence-based and personalized clin-
ical decision supports. The systems demonstrate their scalability to handle different sizes of data 
collected in different clinical settings. Association rule mining is the core of the mining frame-
work, which was introduced in the first part of this chapter. Then I proposed three new rule inter-
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estingness metrics, importance, dominance, and effect for different clinical knowledge interpreta-
tions. Afterwards, I presented the system’s user interface specifically designed for the clinical 
environment.  
 As illustrated in Figure 2.6.1, the systems were evaluated in three different clinical case 
studies, including decision supports in pediatric neuropsychology (neuroARM), predictive health 
(PHARM), and the intensive care (icuARM) with data sizes from small, medium, to large. The 
background, data description, and result of each study are discussed in this chapter, based on their 
original publications in [42-44].  
 
Figure 2.6.1 Three Clinical Decision Support Applications Using the First Version of ARM 
System 
The systems were evaluated in three different clinical case studies, including decision supports in 
pediatric neuropsychology (neuroARM), predictive health (PHARM), and intensive care 
(icuARM) with data sizes from small, medium, to large. 
 
The key innovations of the work in this chapter are: 
• I proposed two rule-based interestingness metrics, i.e., Importance and Dominance, and 
one item-based interestingness metric, Effect, that are all novel in ARM research. I used 
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these three metrics to reveal meaningful clinical interpretations in the icuARM case study 
in the ICU setting. 
• I developed a graphical user interface for users to interactively perform the ARM process, 
which is not available in other ARM systems, especially in the healthcare data mining ar-
ea. 
• I successfully evaluated and demonstrated the proposed ARM system in three clinical set-
tings: neuroARM in pediatric neuropsychology, PHARM in predictive health, and 
icuARM in intensive care. All are the first ARM system in their corresponding medical 
areas. 
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CHAPTER III	  
3 VISUALIZATION FOR EFFECTIVE RULE SEARCH  
3.1 Introduction  
 As discussed in Chapter 1, healthcare informatics can generate explosive knowledge in 
response to the dramatic growth of personalized data. The user (e.g., a clinician) from a non-
computational background is somewhat bewildered by the amount of new knowledge as they are 
by the task of daily clinical practice. The second specific aim of this dissertation was to develop 
an interactive visualization technique that enables accurate and effective knowledge search in a 
fast-paced environment. This aim can be measured by how the visualization improves the usabil-
ity of personalized decision support association rules that I discussed in Chapter 2.  
 In this chapter, I propose a novel visualization technique, called InterVisAR, designed to 
accomplish the second specific aim. The visualization technique is described in the first part of 
this chapter. Since user study is a key step to evaluate a new visualization technique [88, 89], the 
second part of this chapter describes a user study to quantitatively evaluate the performance of 
InterVisAR. To the best of my understanding, this is the first quantitative user evaluation for as-
sociation rule visualization. The work of this chapter aimed to facilitate efficiency and accuracy 
of rule search, especially in a large amount of clinical rules. This work is in preparation for sub-
mission to the IEEE Transactions on Visualization and Computer Graphics (TVCG).  
3.2 Visualization of Association Rules  
 As discussed in Chapter 2, association rules are in the form of X⇒Y, which means that X 
implies Y, where X and Y are called antecedent and consequent, respectively. In its original mar-
keting analysis context, a rule X⇒Y carries the meaning that if a customer purchases items X in 
the basket, he/she is also likely to purchase items Y. The goal of ARM is to find all frequent and 
confident association rules that satisfy two user-specified thresholds: minimum support (Suppmin) 
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and minimum confidence (Confmin). The main advantage of ARM is its ability to discover a huge 
quantity of rules covering all possible relationships that reside in the database. Generally, apply-
ing ARM on a database with n distinct items can generate a set of rules in the order of O(2n). 
However, this fact also becomes one of its main drawbacks. It is because the mining process does 
not guarantee that all the rules found are real patient-specifically meaningful in real world, even 
though they are frequent and confident [90, 91]. Therefore, we need post-hoc processes to im-
prove the quality of rules and make them to be better interpreted, evaluated, and used for further 
actions. 
 Most of the ARM post-hoc process efforts can be categorized into two directions. Efforts 
in the first direction are to improve the quality of rules by pruning redundant rules such as apply-
ing significant tests [92] and identifying non-actionable rules [93]. Although these methods can 
dramatically remove meaningless rules, the resulting rules are still often too large for human in-
terpretation. Therefore, the second post-hoc process direction is to apply visualization approaches 
to transform rules into visual forms for human’s natural visual capabilities.  
 Most of rule visualization techniques are designed to provide a global overview or a 
summary of all rules so as to identify the top meaningful rules. However, a user may want to 
search for a specific rule even though it is not highlighted as top meaningful. Because none of the 
current rule visualization technique is originally designed for rule search, using them to rummage 
a specific rule become inefficient and not intuitive 
3.2.1 Examples of Visualization Techniques for Association Rules 
 There are many visualization techniques have been proposed for association rules. Scatter 
plot is a straight-forward 2-D visualization of association rules [94]. A scatter plot uses support 
and confidence on the two axes so that each rule is represented as a dot. The color of a dot can 
display the third rule metric with a color map on the side of the plot (e.g., lift matric in Figure 
3.2.1a). A special alternation of scatter plot is called two-key plot in which the color of a dot indi-
cates the number of items in the rule [95]. Bayardo and Agrawal suggest that the most interesting 
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rules can be easily visualized using scatter plot since they are usually located on the border of the 
scatter [94].  
 
Figure 3.2.1 Examples of Association Rules Visualization 
Three examples of conventional association rule visualization. (a) Scatter plot with 3,000 associa-
tion rules. The color indicates the lift metric. (b) Matrix-based visualization with the same 3,000 
rules in (a). The color indicates the confidence metric. (c) Graphic-based visualization of nine 
rules from three items. The width of the connection represents a rule’s confidence value.  
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 Matrix-based visualization is another popular technique for association rules. The x- and 
y-axis represent all possible itemsets in antecedent and consequent, respectively. Due to the lim-
ited space of axis labels, itemsets are displayed in numbers to make long itemsets shorter. An as-
sociation rule is plotted at the intersection of its antecedent and consequent itemsets. In the 2-D 
visualization, the color of the intersection can be used for a selected metric (e.g., confidence in 
Figure 3.2.1b). An extension version can use 3-D bars where the height of a bar represents the 
second rule metric [96].  
 Graphic-based visualization [97] represents rules using vertices and edges with directions. 
A rule is a connection starting from an antecedent vertex to a consequent vertex. The width of 
edges can be used to indicate a selected rule metric (e.g., confidence in Figure 3.2.1c). Graphic-
based visualization can comfortably represent association rules if the number of items is small. 
3.2.2 Challenges and Motivation 
 Because none of the aforementioned visualization techniques was originally designed for 
the purpose of rule search, it is difficult to search a specific rule from a large number of rules. In 
scatter plots, each rule is represented as a dot. The user can only hover the pointer over the dot to 
read its antecedent and consequent. It makes it very inefficient to search for a specific rule, espe-
cially when the rules are voluminous. 
 Matrix-based visualization techniques typically show numerical itemset IDs on the x- and 
y-axis due to the limited axis space. Rules with numerical IDs are not human-readable and require 
a mapping process to translate the IDs to real names. In addition, it is very common that a huge 
number of possible itemsets are available, making the plot either very condensed or extend very 
long along the x- and y- axis. Due to these facts, performing rule search using matrix-based visu-
alization becomes intuitive and laborious.  
 Graphic-based visualization can only handle a very small number of rules because it be-
comes cluttered as the result of increased number of vertex and edges. Therefore, graphic-based 
visualization is intrinsically not suitable for finding specific rules. 
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 Assuming there are N possible antecedent items with a fix consequent, the N items can 
generate up to 2N-1 raw rules regardless of Suppmin and Confmin. To search for a target rule with 
a l-itemset (i.e., a set of l items) in antecedent, the user needs to extract a pool of rules that all 
have l items in antecedents and, afterwards, rummage throughout the extracted rules for the target 
l-itemset. Such a searching process poses two main problems especially when the size of N is 
large so that the generated rules are voluminous. 
 Firstly, the efficiency of search mainly depends on the volume of the extracted rules, 
which may have size of rules up to 𝐶!!. For example, when searching for a rule with a 4-item an-
tecedent from a dataset of totally eight items (N = 8), the user need to extract and rummage the 
rule through a pool of 70 (i.e., 𝐶!!) rules. If one more possible item is added to the database, the 
size of the extracted rule pool increases to 126 (i.e., 𝐶!!). That is, it increases 80% of search load-
ing by simply adding one possible item even for the same target antecedent.  
 Secondly, it is intuitive that rules with long antecedents require longer searching time 
than those with short antecedents. However, in a dataset with eight possible items (N = 8), search-
ing for a rule with a 4-item antecedent may require a longer time compared to searching for an-
other rule with a 7-item antecedent, which counters our intuition. That is because the former re-
quires the user to rummage in a pool of 70 (i.e., 𝐶!!) rules, but only eight (i.e., 𝐶!!) in the later.  
Based on the two aforementioned challenges, we can summarize that the effort required to search 
a rule should only monotonically increases for longer antecedents, instead of being factorially 
influenced by the number of total possible items N (i.e., 𝐶!!). I call this non-factorial property and 
addressing this property is one of my main motivations. 
3.3 InterVisAR 
 InterVisAR is a post-hoc process performed after all rules are generated by ARM. It is 
based on an assumption that all rules share the same consequent specified during the mining pro-
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cess. It is not necessary to prune rules aforehand, meaning that the visualization can handle all 
possible rules regardless of the Suppmin and Confmin.  
 As depicted in Figure 3.3.1, the visualization consists of rows of horizontal lines. Y-axis 
represents full names of the row items, instead of showing their ID numbers. X-axis, spanning 
from 0% to 100%, is used for support and confidence values. Two static vertical dashed lines 
show the Suppmin (in green) and Confmin (in blue). Each row is composed of one horizontal sup-
port line (in green) and one horizontal confidence line (in blue). The visualization updates these 
row items iteratively based on user selection. 
 Initially, without any selection, the support and confidence lines of each item span from 0% 
to the potential support and confidence values. If any item has been selected (i.e., the antecedent 
itemset is not empty), the plot adds two vertical solid lines displaying the current support, 
Suppcurrent, in green and confidence, Confcurrent, in blue. Afterwards, each remining item is up-
dated accordingly: the support line spans from Suppcurrent to one end indicating the change of 
support value if we add the potential row item to the selected antecedent itemset. Similarly, the 
confidence line spans from Confcurrent to one end indicating the potential change of confidence 
value. A solid dot located at the end indicates that the change is significant; otherwise, a hollow 
dot is presented. These graphic components provide the following usages: 
• We can determine which potential items can increase/decrease the current support (confi-
dence), i.e., towards the right/left of the vertical Suppcurrent (Confcurrent) line. 
• We can determine which potential row items can still keep the rule frequent, i.e., the hor-
izontal support (green) lines remain on the right of vertical Suppmin line. Similarly, we 
can tell which potential items can still keep the rule confident in comparison with the ver-
tical Confmin line. 
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• We can determine if the rule of current selected antecedent itemset is frequent (confident), 
i.e., the vertical Suppcurrent (Confcurrent) line is on the right of the vertical Suppmin 
(Confmin) line. 
 Several interactive features are available to make the visualization friendlier. When the 
user hovers the mouse over a row item (e.g., ‘Low SpO2’ in Figure 3.3.1-a), the visualization dis-
plays corresponding values at the ends of the vertical lines. In addition, upon selection (by mouse 
click) of a row item, the visualization updates the “Current Items” table by adding the newly se-
lected item (e.g., ‘Low SpO2’ in Figure 3.3.1-b).  
 
Figure 3.3.1 Example of InterVisAR Visualization 
An example of InterVisAR visualization algorithm with seven items. (a) The initial plot without 
any selected items. The cursor hovers on a next-level items ‘Low-SpO2’ with its corresponding 
potential support, confidence, and maximal confidence. (b) The updated plot after the item Soda 
has been selected. Two out of the six potential items can change the confidence significantly. 
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 The InterVisAR algorithm updates the visualization components based on the interactive 
user selection. I describe the setting of the algorithm as follows. Assuming we have extracted a 
set of raw rules R in which each rule r has four elements, including r.a as the antecedent itemset, 
r.l as the length (i.e., the number of items) of r.a, r.supp as the support, and r.conf as the confi-
dence. The goal of the visualization is to find a rule with a target antecedent itemset. Suppmin and 
Confmin are also known and are inputs of the algorithm. 
 The visualization starts by displaying all rules with 1-item antecedents. The process 
keeps updating the visualization by interactively receiving the user’s selection of next-level items. 
Each update refreshes the remaining next-level row items, support and confidence lines, and the 
vertical Suppcurrent and Suppcurrent lines. The level-by-level process continues until the rule of target 
antecedent itemset has been found. A reset function is provided to restart the entire process.  
The complete algorithm of InterVisAR is provided in Figure 3.3.2.  
  
Figure 3.3.2 Algorithm of InterVisAR 
  57 
In the following I provide some notes about the InterVisAR algorithm: 
• Line 1 draws Suppmin and Confmin in two vertical dashed green and blue lines, respectively. 
• In line 2, according to the sort_type input, all raw rules R can be sorted in three ways: al-
phabetically (a to Z or Z to a) by row item names or numerically (descending or ascend-
ing) by potential support or confidence values. Figure 3.3.1(a) and (b) are two examples 
sorted by confidence values.   
• Line 3 initializes the current selected rule rcurrent with rcurrent.a = ∅, rcurrent.l = 0, rcurrent.supp 
= 0, and rcurrent.conf = 0. 
• Line 4 updates the two vertical Suppmin and Confmin lines to rcurrent.supp and rcurrent.conf, 
respectively. 
• In line 5, the extractNextLevelRules(rcurrent, R) extracts a rule pool W in which each next-
level rule r satisfies r.l = rcurrent.l + 1 and rcurrent.a ⊂ r.a.  
• If W is not empty in line 6, the algorithm cleans up the visualization in line 7. Otherwise, 
the visualization halts in line 22 and waits for the user to reset.  
• From line 8 to line 16, each next-level rule r in W is process one-by-one.  
• Line 9 excludes rcurrent.a from each r.a and labels the remaining item in y-axis. 
• Line 10 adds a horizontal support (green) line from rcurrent.supp to r.supp, and line 11 adds 
a horizontal confidence (blue) line from rcurrent.conf to r.conf. 
• Lines 12 tests if rcurrent.supp and r.supp, and rcurrent.conf and r.conf, are statistically differ-
ent. We use binomial test since the outcome of association rules is binary (i.e., the conse-
quent is hold or not). The test is performed at two-tailed 95% significance level. If the 
change of support is significant, line 13 places a solid green circle at the end of the sup-
port line; otherwise, places a hollow circle (line 14).  Similarly, if the change of confi-
dence is significant, line 15 places a solid blue circle at the end of the confidence line; 
otherwise, places a hollow circle (line 16).   
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• After updating all next-level rules in W, the system halts and waits for one out of three 
user actions that can trigger line 17, 19, or 21, respectively. 
• Line 17 is triggered if the user selects any item from the “Select Items” table. Line 18 
removes the selected item i from rcurrent.a, and the process repeats from line 4. 
• Line 19 is triggered when a next level-rule r is selected from W. Line 20 sets rcurrent = r 
and repeats from line 4.  
• The entire visualization can be reset anytime in line 21. If triggered, the process repeats 
from line 3. 
• Finally, the process reaches line 22 only when the extracted W ≠ ∅. Users can reset the 
process to line 3.  
3.4 User Study 
3.4.1 Background and Motivation 
 In the predictive health study discussed in Chapter 2.5.2, I reported a system called Pre-
dictive Health Association Rule Mining (PHARM) for the generation of quantitative and objec-
tive rules in predictive health settings [64] by leveraging a dataset collected from 696 healthy 
subjects. However, the mined rules in PHARM system were presented using tables, which were 
reported inefficient for searching specific rules by the clinical users. Thus, in this study, I used the 
predictive health data to evaluate the improvement of rule searching using InterVisAR by com-
paring to table-based representations. Note that InterVisAR was not compared to other rule visu-
alization techniques because none of them was originally designed for rule searching purposes so 
that the comparison may be biased. My goal of this user study was (1) to evaluate how much per-
formance regarding rule search efficiency and accuracy that InterVisAR can achieve, (2) to assess 
if InterVisAR satisfy the non-factorial property, and (3) to demonstrate that InterVisAR is a pre-
ferred rule searching tool according to user satisfaction.    
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3.4.2 Method 
3.4.2.1 Dataset 
 I used the data from the case study discussed in Chapter 2.5.2 [43] that discovered predic-
tive rules for mental illness based on scale scores of seven psychological disorders, including 
family dysfunctioning, lack of social support, depressive, perceived empathic self inefficacy, 
sleepiness, dysfunctioning due to cancer therapy, and anxiety. In other words, there were totally 
seven available antecedent items (i.e., N = 7) and one fixed consequent. As listed in  
Table 3.4.1, each antecedent item was composed of a scale name and a numerical disorder range. 
The seven antecedent items allowed the PHARM system to generated 127 (i.e., 27 - 1) raw rules 
that had lengths between one and seven, as examples provided in Table 3.4.2. 
Table 3.4.1 InterVisAR User Study - Antecedent Items and Their Corresponding 
Scales 
Item Scale Name 
BDI>9.1 Beck Depression Inventory 
ESSI< 23.9 Enriched Social Support Inventory 
EPWORTH>10.3 Epworth Sleepiness Scale 
FACT<60.6 Functional Assessment of Cancer Therapy 
FAD> 2.3 Family Assessment Device 
GAD7> 6.1 Generalized Anxiety Disorder 7-item 
PSSE> 25.4 Perceived Empathic Self-Efficacy Scale 
 
Table 3.4.2 InterVisAR User Study - Examples of Antecedent with Different 
Lengths 





1 GAD7>=6.1 7 
2 ESSI<=23.9 & PSSE>=25.4 21 
3 BDI>=9.1 & FAD>=2.3 & GAD7>=6.1 35 
4 BDI>=9.1 & EPWORTH>=10.3 & FAD>=2.3 & GAD7>=6.1 35 
5 EPWORTH>=10.3 & FACT<=60.6 & FAD>=2.3 & GAD7>=6.1 & PSSE>=25.4  21 
6 BDI>=9.1 & EPWORTH>=10.3 & ESSI<=23.9 & FAD>=2.3 & GAD7>=6.1 & PSSE>=25.4 7 
7 BDI>=9.1 & EPWORTH>=10.3 & ESSI<=23.9 & FACT<60.6 & FAD>=2.3 & GAD7>=6.1 & PSSE>=25.4 1 
 Total 127 
 
3.4.2.2 Participants 
 The user study recruited 24 participants (12 females and 12 males). All participants had 
normal computer operation skills. Each participant performed the experiment on an individual PC 
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with two 20.1” wide aspect LCD monitors. The left screen displayed training information and 
experiment tasks, and the right one was used for performing tasks. The interface of the system 
was implemented in MATLAB (MathWorks, Natick, MA). 
3.4.2.3 Tasks 
 Participants were asked to perform two types of tasks: 
T1. Rule Search. Given a target antecedent itemset, the participant tried to find the rule with 
the itemset by answering its support and confidence. 
T2.  Next-level Item Search. Given a target antecedent itemset, the participant tried to find a 
next-level antecedent item so that the new rule combining with this next-level item and 
the original target itemset can have the highest confidence comparing to all other next-
level items. 
3.4.2.4 Rule Presentations 
 Each task was performed by four table-based (starting with T) and two visualization-
based (starting with Vis) rule presentations, including: 
   T. Table with rules sorted in ascending order by antecedent length.  
TO. Table with rules sorted ascending order by antecedent length. In each rule, items were 
sorted alphabetically (a to Z) by name.  
TL. Table with a slider bar controlling the length of displayed antecedents. Displayed rules 
were sorted in descending order by confidence value.  
TLO. Table with a slider bar controlling the length of displayed antecedents. Displayed rules 
were sorted alphabetically (a to Z) by name.  
VisC. InterVisAR with next-level items sorted in descending order by their confidence value.  
VisA. InterVisAR with next-level items sorted alphabetical (a to Z) by name.  
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3.4.2.5 Procedure 
 Before each study, the participant received a training session to understand the basic con-
cept of association rules, the PHARM dataset, the tasks, and the rule presentations. Afterwards, 
participants were randomly assigned to two groups (G1 and G2) balanced by gender. As shown in  
Table 3.4.3, participants in two groups were associated with two different sets of rule presenta-
tions. Each set consisted of three rule presentations that are exclusive with those in the other 
group. Performing tasks using only three presentations, instead of all six, allowed us to control a 
study to be completed within 60 minutes so as to prevented fatigue from prolonged operation 
time. In this way, each participant performed six (2x3 task-presentation) sections. Participants 
were required to practice before the start of each section until they were fully ready.  
Table 3.4.3 InterVisAR User Study - Groups, Tasks, Methods, and # of Queries 
  No. of Queries/Subject 
 Group 1 2  







T 12 8   
TO   12 8 
TL 12 8   
TLO   12 8 
VisC 12 8   
VisA   12 8 
 
 Target rules in T1 (T2) sections were associated with antecedent lengths between one and 
six (four). Each length was queried twice so that 12 participants generated 24 (12x2) records of a 
length. In summary, this user study was conducted as a design of 2 groups x 12 participants x 2 
tasks x 3 rule presentations x 6 different lengths in T1 (or 4 in T2) x 2 queries. Finally, after com-
pleting a task using three different presentations, participants provided their ranking among the 
three presentations in performing this task via a Likert scale from 3 (the favorite) to 1 the (the 
worst). Multiple presentations with the same rank were acceptable. 
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3.4.2.6 Measures 
 The record of a query contained two measures, including completion time (i.e., the time 
from being queried to the time being answered) for efficiency and a hit or miss (i.e., if the answer 
is correct or not) for accuracy. The efficiency of an antecedent length in a task-presentation sec-
tion was analyzed using all 24 completion time records collected from the group’s 12 participants. 
Similarly, the accuracy of an antecedent length in a task-presentation section was analyzed using 
all 24 hit/miss records collected from the 12 participants in a group.  
 Using the efficiency and accuracy measures, this study introduced a new measure to de-
termine a participant’s overall accurate rules per minute (ARPM) for a specific length in each 
task-presentation section, which is calculated as: 
 
Finally, using collected user study data, I performed repeated-measure analysis of variance (RM-
ANOVA) to investigate if the performances were significantly affected by different lengths in 
different rule presentations. 
3.4.3 Results and Discussion 
3.4.3.1 Hypotheses 
 Based on the three searching aspects (i.e., efficiency, accuracy, and ARPM), I made the 
following hypotheses: 
H1. In rule search task (T1), InterVisAR outperforms table-based rules in all three aspects. 
H2. In rule search task (T1), InterVisAR satisfies the non-factorial property in all three as-
pects. 
H3. In next-level item search task (T2), InterVisAR outperforms table-based rules in all three 
aspects. 
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H4. In next-level item search task (T2), InterVisAR satisfies the non-factorial property in all 
three aspects. 
 Regarding to the user preference, I hypothesized the following:   
H5. InterVisAR is preferred in rule search (T1). 
H6. InterVisAR is preferred in next-level item search (T2).  
3.4.3.2 Rule Search 
 The results of rule search in three aspects, including efficiency (i.e., the inverse of the 
completion time), accuracy, and ARPM, are illustrated in Figure 3.4.1. I verified H1 by observing 
that InterVisAR, mainly, outperformed all table-based presentations in all aspects regardless of 
length, table control, and sorting. The efficiency of InterVisAR decreased in longer rules, but the 
accuracy was consistently high. As for sorting types, InterVisAR with alphabetical sorting (VisA) 
slightly outperformed it with confidence sorting (VisC) in all three aspects. It was reasonable be-
cause rules were searched by names instead of confidence values. 
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Figure 3.4.1 InterVisAR User Study - Results of Rule Search 
Results of rule search using six rule presentations in six different lengths: (a) completion time, (b) 
accuracy, and (c) accurate rules per minute (ARPM). (d) Comparisons among the six methods 
and their statistics of differences. 
 
 InterVisAR also demonstrated the non-factorial property in all three aspects (H2). For 
example, the ARPM of InterVisAR monotonically decreased in longer rules, instead of being fac-
torially affected by the total number of available items. On the contrary, table-based rule presen-
tations all lacked the property with respect to all three aspects. For example, tabulated rules with 
length control and alphabetical sorting (TLO) lacked the property even though it was the one per-
formed most closely to InterVisAR. I can verify it as the completion time for 6-item rules was 
shorter than 5-item rules. 
3.4.3.3 Next-Level Item Search 
 It can be expected that the performance is longer in the task of next-level item-search 
than it in the rule search task. It was because the participants needed to first extract all possible 
  65 
next-level rules, compared confidences among them, and finally identified the one with the high-
est confidence. This procedure was overwhelming using table-based presentations. As expected, 
according to Figure 3.4.2, InterVisAR outperformed all table-based presentations in all three as-
pects, verifying H3. Similar to rule search, InterVisAR with alphabetical sorting (VisA) still 
slightly outperformed it with confidence sorting (VisC) except for 1-item antecedents.  
	  
Figure 3.4.2 InterVisAR User Study - Results of Item Search 
Results of next-level item search using six rule presentations in four different lengths: (a) comple-
tion time, (b) accuracy, and (c) accurate rules per minute (ARPM). (d) Comparisons among the 
six methods and their statistics of differences. 
 
 The results of InterVisAR also demonstrated the non-factorial property in all three as-
pects, which verified the hypothesis H4. For example, the APRM using InterVisAR monotonical-
ly decreased, but not factorially, in longer antecedents. Not surprisingly, table-based presentations 
(other than TL) all lacked the property. It was interesting that tabulated rules controlled by ante-
cedent length and sorted by confidence (TLO) also showed the non-factorial property. It was 
mainly because the participants can easily extract potential next-level rules by using the slide bar. 
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Afterwards, the top one of the extracted rules was the final rule because they were sorted by con-
fidences, which skipped the need for rule comparison. However, InterVisAR still outperformed 
TLO in all aspects in addition to its non-factorial property.  
3.4.3.4 User Preference 
 The results of user preference are depicted in Figure 3.4.3. Participants were more com-
fortable and pleased using InterVisAR in both rule-searching (H5) and next-level item-searching 
tasks (H6) compared to all other table-based presentations (all had p < 0.01).  As for table-based 
presentations, participants preferred those with more rule length controls and sorting. For exam-
ple, the two presentations with length control (i.e., TL and TLO) were more favored than T and 
TO, respectively. 
 
Figure 3.4.3 InterVisAR User Study - User Preference 
User rankings for different methods in two tasks. All rankings reveal significant differences. 
3.5 Future Opportunities  
 The aforementioned results positively supported my six hypotheses. However, this study 
still revealed several future opportunities: 
 First, InterVisAR was designed based on the assumption that all association rules have a 
predetermined and fixed consequent. It makes the visualization more suitable for classification-
based association rules in which there is one and only one target consequent (i.e., the class) [98]. 
However, in real-world association rule search, consequents are not necessary and nearly fixed. 
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Therefore more sophisticated approaches should be proposed and investigated for flexible conse-
quents. They should also satisfy the non-factorial property to guarantee the performance. 
 Second, the predictive health dataset used in the user study only consisted of seven items. 
I believe that the demonstration of the non-factorial property using InterVisAR would be more 
prominent when we significantly increase the number of all available items, which accords more 
with real-world cases. 
 Third, in the user study, I divided the 24 participants into two groups to perform tasks 
using two different sets of rule presentations. However, the user didn't have chance to crossly 
compare the preference between these two groups. For example, it was difficult to determine 
which type of sorting in InterVisAR (i.e., VisA and VisC) was preferred because no participant 
performed tasks using both of them. I remark this issue because a few participants in G1 suggest-
ed methods in G2, and vice versa.  
 Fourth, InterVisAR has the ability to visualize potentially maximal confidences (i.e., the 
T-shape locations in the plot) of all possible next-level items. However, searching for potentially 
maximal confidences is extremely difficult to perform using tabulated rule presentations. This 
task was excluded from the user study because it might cause prolonged study on participants. A 
separate user study can be conducted for this task, but the current results have already implied 
that InterVisAR can outperform tabulated methods in searching for rules with maximal confi-
dence. 
 Finally, the current visualization only demonstrated the capability of two basic rule met-
rics: support and confidence. However, rules can be measured using other objective interesting 
metrics, such as conviction [99], leverage [100], interest factor [101], and p-values using chi-
square test [92]. A better visualization can be proposed and investigated to support comprehen-
sive interesting metrics so that users can select metric of interest to visualize. 
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3.6 Summary and Key Innovations 
 This chapter introduced an interactive association rule visualization, called InterVisAR. 
InterVisAR was designed specifically for association rule searching, which is different from con-
ventional rule visualization techniques that only provide an overview or a summary of all rules. 
The visualization interactively receives user inputs step-by-step until all items in a target rule 
have been found. Based on the user’s selection, InterVisAR visualizes information about all next-
level items, including potential next-level supports and confidences, and potential maximal confi-
dences. InterVisAR delivers most association rule information in a small view without over-
whelming user panning and scrolling.  
 This chapter also discussed a non-factorial property that a rule-searching visualization 
should satisfy to guarantee the performance. To verify it in InterVisAR, a user study was con-
ducted to compare InterVisAR to table-based rule presentations with different rule controls and 
sortings. The results confirmed that InterVisAR not only outperformed table-based rule presenta-
tions (in terms of efficiency, accurate, and accurate rule per minute (ARPM)), but also satisfied 
the non-factorial property. Participants also expressed strong preferences for InterVisAR because 
it promises a comfortable and pleasing rule-searching solution.  
 The key innovations of the work in this chapter are: 
• The work in this chapter discusses and proposes a novel solution for the non-factorial 
property. 
• InterVisAR is the first ARM visualization technique that is specifically designed for as-
sociation rule search. 
• I conducted a user study to evaluate the improvement of accuracy and efficiency using 
InterVisAR for rule search. The use study is the first one in the development of new 
ARM visualization. 
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CHAPTER IV	  
4 CASE-BASED TEMPORAL ASSOCIATION RULE MINING AND RULE SE-
LECTION 
4.1 Introduction 
 A majority of ARM applications, including my work presented in Chapter 2, only con-
sider co-occurrence between antecedent and consequent without the ability to reveal their tem-
poral relationships. For example, a rule {blocked urinary tract} ⇒ {creatinine > 1.3 mg/dL} can 
only be used to find the coexistence between blocked urinary tract and creatinine > 1.3 mg/dL. It 
is not capable of revealing if a patient who has blocked urinary tract will develop abnormal creat-
inine level in the next 24 hours, even though the patient’s creatinine level is currently normal. 
Although a few temporal ARM approaches have been proposed [102, 103], they were not de-
signed for users to specify flexible time windows in the antecedent and consequent, and they 
lacked applications in the healthcare area.  
 This chapter introduces a case-based temporal association rule-mining framework that 
can flexibly capture the nature of temporal relationships between the antecedent and the conse-
quent. The chapter first provides the background of the case-based clinical data mining. Then it 
introduces a case-based temporal association rule-mining framework with a rule selection process 
that can estimate better calibrated prediction as compared to conventional confidence-only rule 
selection. The framework is also implemented in the second version of my ICU clinical decision-
support system, called icuARM-II. To demonstrate its usability, a part of this chapter presents its 
graphical user interface followed by a case study using abnormal lab-testing results for the predic-
tion of short-term ICU mortality. Finally, the end of the chapter remarks key innovations. The 
background, data description, and result of the study in this chapter are based on its original pub-
lications in [104]. 
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4.2 Cased-Based Clinical Data Mining 
 Case-based reasoning (CBR) is a process of adapting old knowledge to solve new de-
mands, using old cases to explain new situations, or interpreting new problems from previously 
reasoned procedures [105]. A clinical CBR system must have a process of self-learning process 
and a ability to reuse its own experience [106]. The original five steps of CBR [107] starts from 
(1) assigning indexes. Indexes are features that characterize a decision support knowledge and 
determine how knowledge is stored as cases. (2) Case retrieval. It allows the system to retrieve 
similar cases that can be used to solve the new clinical problem. (2) Case adaption. In CBR, it is 
very common that none of the old cases can exactly solve the new problem. Thus, the idea of old 
cases can be used as an inspiration for solving the new problem, which requires the system to 
adapt from the old ones. (4) Case testing. The retrieved or newly learnt cases should be evaluated 
to determine how they could solve the new problem. (5) Case storage. Once the new problem is 
solved, the corresponding verified case knowledge should be stored for future use.  
 CBR has been adopted in many healthcare decision support applications. For example, 
CASEY is one of the earliest medical decision support systems that apply CBR [108]. It proposed 
a concept of general adaption operators in an ambitious attempt to solve the adaption task for the 
condition of heart failure diagnosis. Then Evans presented a CDSS designed for the assistance for 
medical specialists of dysmorphology [107]. The proposed interactive CBR model aids medical 
users to determine potential diagnoses with an explicit learning goal to provide further analytical 
assessment of syndrome categories. The BOLERO system, proposed by Lo ́pez and Plaza in 1997 
[109], is a CBR system that learns both clinical plans and goal states to improve the performance 
of rule-based clinical diagnosis using most recent information obtained from patients. Frize and 
Walker [110] proposed a CBR-based clinical decision support system for the estimation of medi-
cal outcomes and resource utilization. This system provides a view to help medical personnel 
(e.g., nurses) to assess patient condition, provide clinical decision support, and improve the selec-
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tion of appropriate procedures. CBR is also a good fit for bioinformatics applications with large 
amounts of data, and unknown and incomplete knowledge. The Gene Finder [111] and the Nutri-
Genomics [112] are two examples. Gene Finder analyzes for the identification of DNA segments. 
The case library consists of nucleotide segments that have been classified to find the regions in 
previously unseen DNA strands. The system demonstrates the viability to improve gene therapy 
by identifying the alteration of genes that cause diseases.  
 CBR is argued to be very effective in the medical domain, such as its natural process for 
healthcare professionals who have been using historical experience in practice, and its automatic 
acquisition, cognitive adequateness, duality of objective and subjective knowledge, explicit expe-
rience, and system integration [113]. However, the integration with electronic medical records in 
real healthcare settings is rare, which has been identified as one of key trends and opportunities 
by Bichindaritz [113]. With close integration of EHR systems, CBR-based CDSS can provide a 
safe [114] healthcare environment to incorporate standards of care, in particular, evidence-based 
medical practice [115]. Therefore, in the following part of this chapter, I propose a case-based 
clinical knowledge-mining framework that generates temporal association rules as cases and 
evaluate the consistency of cases based on a patient’s specific clinical conditions.  
4.3 Temporal Association Rule Mining 
 Similar to the items in non-temporal association rules, the basic element in temporal as-
sociation rules is called an event. Given a temporal database with time-stamped entities, there are 
two types of mechanisms for the generation of event sequences: state events,  which convert qual-
itative values into categorical (e.g., low, high, or normal) states in a time series, and trend events: 
which capture continuous trend courses (e.g., increasing, decreasing, or stationary) in a time se-
ries.   
 Assuming E = {E1, E2, … , EN} is a set of defined events, the framework can construct an 
episode P = {EP | TP} with a set of events EP ⊆ E within a time interval TP. TP is composed of TP,s 
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and TP,e, TP,e > TP,s, indicating the start time and the end time of TP. TP,s and TP,e can be specified, 
for example, TP = {Tadmission, Tadmission + 24-hr} specifies a time interval between the time of 
admission and 24 hours after then. TP can also be an arbitrary interval; for instance, |TP| < 12-hr 
means all TP,s and TP,e that TP,e - TP,s < 12-hr. In this way, a temporal association rule (TAR) can 
be represented as A ⇒ C: {EA | TA} ⇒ {EC | TC}. All of the EA, EC, TA, and TC are the user inputs 
for the mining process. The rule indicates that when an antecedent episode A with events EA ob-
served within the past TA, another consequent episode C with EC in the following TC will also be 
likely to occur in a certain possibility. The framework restricts the mining to the case where an 
antecedent episode is followed by a consequent episode, i.e., TA,e = TC,s. Several use cases can be 
derived based on different settings of TA and TC, as listed and illustrated in Table 4.3.1. 
Table 4.3.1 Use Cases and Examples with Different Settings of TA and TC in tem-
poral Association Rules  
 
 Given all available event sequences and target antecedent and consequent episodes, the 
mining framework processes a rule and generate a 2x2 contingency table that can be used to de-
rive a variety of rule metrics, including the support and confidence. As shown in Figure 4.3.1, the 
contingency table of a rule A ⇒ C: {EA | TA} ⇒ {EC | TC} is presented by four cells, c11, c12, c21, 
and c22, which are the counts of (A, C), (A, 𝐶), (𝐴, C), and (𝐴, 𝐶), respectively. 𝐴 (or 𝐶) indicates 
the situation that the antecedent A (or the consequent C) is not detected. If the start time and end 
time of TA (or TC) are specified (e.g., TA = {Tadmission, Tadmission + 12 hr}), the framework directly 
extracts all events within that time window and determines if the extracted events match EA (or 
Setting Illustration Prediction Example 
TA ≠ 0, TC ≠ 0  
 
After finishing two treatments E1 and E2 in a period of TA, 
what is the possibility of the development of high heart 
rate (E3) and low arterial pH (E4) in the following TC? 
TA = 0, TC ≠ 0 
 
After taking a drug E1, what is the possibility of the devel-
opment of high blood pressure (E2) and high creatinine 
level (E3) in the following TC? 
TA ≠ 0, TC = 0 
 
Upon finishing of two treatments E1 and E2 in a period of 
TA, what’s is the possibility of development of low pulse 
oximetry (E3) at the end of TA? 
TA = 0, TC = 0 
 
What is the possibility that low white blood cell counts 
(E1) coexists with low urine output (E2)? 
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EC). Based on the result, the framework updates the four cells accordingly. If the time window of 
TA (or TC) is arbitrary (e.g., |TA| < 12-hr), then the framework performs two types of scanning on 
event sequences to count these four cells.  
 
Figure 4.3.1 Contingency Table of a Temporal Association Rule A ⇒  C. 
4.3.1.1 Backword and Forward Scanning 
 If TA and TC are arbitrary, the framework performs a backward scanning followed by a 
forward scanning on each event sequence, as depicted in Figure 4.3.2. For an event sequence, the 
backward scanning starts from the last event and traces back towards the first event. Whenever an 
antecedent episode A is found (i.e., scanned events contain EA within a time window TA) with the 
last event occurring at time t, the framework extracts potential consequent events between t and t 
+ TC. If potential consequent events contain EC (i.e., C is scanned), then the framework adds c11 
by one, and the scanning stops for this event sequence; otherwise, the backward scanning contin-
ues. If the backward scanning can only detect an antecedent episode but no consequent episode 
throughout the sequence (i.e., (A, 𝐶)), the framework proceeds to the forward scanning.  
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Figure 4.3.2 Flow of Backward and Forward Scanning (Top) with Examples of Five Differ-
ent Situations (Bottom). 
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 The forward scanning starts from the first event towards the last event of a sequence. 
Whenever a consequent episode C is found (i.e., events contain EC within a time window TC) with 
the first event occurring at t, the process extracts all possible antecedent events occur between t – 
TA and t. If all extracted antecedent events contain EA, the process updates the contingency table 
depending on whether (A, 𝐶) has been detected in the backward scanning phase. If yes, the 
framework adds both c12 and c21 by half; otherwise, it adds only c21 by one. If the process finds no 
matched episodes for EC in forward scanning, again, the process updates the contingency table 
depending on whether (A, 𝐶) has been detected in the backward scanning phase. If yes, the 
framework adds c12 by one; otherwise, it adds c22 by one. 
 The scanning mechanism ensures that the sum of the four cells in the contingency table is 
added one by one for each event sequence. It is possible that both c21 and c21 are added by half 
since a sequence can have both antecedent episode and consequent episode occur separately, as 
the example b in Figure 4.3.2.  
4.3.1.2 Rule Generation with Fixed Target Consequent 
 The proposed temporal mining framework assumes that all rules share one and only one 
pre-determined consequent episode C (i.e., the target outcome). Let E = {E1, E2, …, EN} are N 
possible antecedent events (i.e., observed patient conditions), the framework aims to discover a 
case list in which are all confident temporal association rules with different combinations of these 
events in antecedents. The framework utilizes a two-step process to generate frequent and confi-
dent rules according to the specified Suppmin and Confmin, respectively. The first step is iterative, 
starting by generating contingency tables of candidate 1-event rules that contain only one event in 
the antecedent episode. Assuming the total number of event sequences is NS, candidate 1-event 
rules that have c11/NS lower than Suppmin are pruned out and the remaining ones are called fre-
quent 1-event rules. In the following iterations (i.e., k>1), the framework first uses frequent (k-1)-
event rules to generate candidate k-event rules. Candidate k-event rules that have c11/NS lower 
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than Suppmin are pruned out and the remaining ones are called frequent k-event rules. The iteration 
continues until no more frequent rules can be found. Given all frequent rules, in the second step, 
the framework prunes out rules that have c11/(c11+c12) lower than Confmin, and the remaining ones 
are called confident rules. In this way, N potential antecedent events can generate a decision list 
with up to (2N – 1) raw rules, and infrequent or unconfident rules can be pruned by applying the 
Suppmin and Confmin, respectively. 
4.4 Quality Assessment of Personalized Rules 
4.4.1 Causality of Association Rules 
 The studies discusssed in Chapter 2 have demonstrated the viability of association rule 
mining in a variety of clinical settings, including pediatric neuropsychology, predictive health, 
and the intensive care. However, association rules mined from data can be spurious and do not 
reflect true casuality between the antecedent and consequent. Thus association rule mining cannot 
be called ‘causality’ analysis because the rule cannot imply the relation between an antecedent 
(the cause) and a consequent (the effect), where the effect is understood as a physical 
consequence of the cause. This means that many of mined rules may not have practical meaning 
if not being verified by human knowledge. While the development of reliable mining process for 
finding causality patterns in clinical data, the determination of real causes given a target outcome 
has become prominent. 
 Casual relationships imply the real data generation mechanisms and how the outcome 
would be effected when the cause is changed [39]. The gold standard for conventional casual 
analysis is ramdomized control trials (RCTs). However, RCTs are infeasible in personalized 
knowledge mining because the data collected in the trial may not be applicable to an individual’s 
specific characteristics. In addition, due to the high dimensionality of clinical data, applying 
conventional statistical analysis for casual analysis become incapable. Casual analysis has been 
applied in clinical knowledge mining, such as the assessment of whether the association of serum 
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homocysteine concentration with ischaemic heart disease, deep vein thrombosis and pulmonary 
embolism, and stroke is causal and, if so, to quantify the effect of homocysteine reduction in 
preventing them [40]. However, applying casual analysis in clinical knowledge discovery is rare 
even though the association rules can still be indicators for casual relationships [41]. Therefore, 
combining other data minig technologies with association rule mining can expand its viability for 
casual analysis, which is important when the determination of potential causes for a target clinical 
outcome based on a patient’s individual characteristics. 
 As described previously in conventional association rule mining, we can assess if a rule 
X⇒Y has a high level of association according to its confidence value. However, a high confi-
dence of rule X⇒Y still cannot guarantee a low confidence of its counter case ( ), which 
means that the observed conditions X may not really be the cause of the target outcome Y. During 
clinical decision support, the mining process should consider when the rule X⇒Y yields a higher 
confidence than its antecedent’s counter case (i.e., ). This means that Y is likely to occur 
only when X occurs. When X does not occur, Y has a low chance of occurrence. The following 
equation can be used to calculate the causality ratio of a rule X⇒Y:   
 
The causality ratio ranges from 0 to ∞. Value of 1 is an important threshold for the ratio. A rule 
with causality < 1 means that the antecedent predicts the consequent worse than the counter case 
of the antecedent, meaning that the causality of the outcome given the antecedent is low.  This 
type of rule should be ignored and all rules are expected to have causality ratios > 1.   
4.4.2 Rule Selection Based-on Both Confidence and Causality 
Given a patient with a set of observed conditions, the temporal mining framework that 
mentioned in the previous part of this chapter aims to discover a case list in which are all confi-
dent temporal association rules with different combinations of observed events in antecedents. 
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Assuming the patient has N observed conditions, the mining framework can generate a case list of 
up to 2N – 1 raw rules regardless of the Suppmin and Confmin. 
 Many methods have been proposed to determine the final prediction possibility based on 
the confidence values in a rule list. The most common strategy is called Classification Based on 
Association (CBA) that uses the selected rule’s confidence values for classification purposes. 
CBA was empirically found to have better prediction accuracy than C4.5 on a variety number of 
datasets [116]. CBA uses a heuristic method to construct a classifier in which all rules in the deci-
sion list are ordered decreasingly according to their confidence and support values. When classi-
fying a new tuple, the first rule (i.e., the rule with highest confidence) satisfying the tuple is used 
to classify it. For example, a set of clinical conditions E = {E1, E2, E3, E4} from one patient can 
generate a case list of rules in which the first rule R1 with antecedent events {E1, E2} has a high 
confidence of 99%. The CBA classifies a new tuple according to this rule. However, the decision 
list may contain other two rules R2 and R3 with antecedent events {E1, E3, E4} and {E1, E4} with 
confidence values of 40% and 38%, respectively. If all rules in the case list are similar to R2 and 
R3 that tend to have low confidence values, it may imply that the estimated prediction is not re-
producible because not all generated rules can guarantee not only high but also consistent confi-
dence values. The high confidence of R1 might happen by chance. In this situation, classifying a 
new tuple using R1 in CBA becomes problematic.  
 To improve the rule selection performance, I propose a novel strategy that generates the 
final outcome prediction depending not only on all rules’ confidence values but also on their cau-
sality ratios. As illustrated in Figure 4.4.1, given a patient who has N observed conditions with a 
fixed target outcome, the mining framework can generate a case list of 2N – 1 raw rules. The rule 
selection process first discards those rules with zero support values and causality ratios < 1 so as 
to guarantee that antecedents in all rules can be considered as potential causes with respect to the 
target outcome. Afterwards, the process generates two rankings on all remaining rules: one rank-
ing (R1) based on confidence values, and the other ranking (R2) based on causality ratios. A final 
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ranking is decided by the summation of R1 and R2. With the final ranking, the process extracts 
the top NR rules and calculates the average of their confidence values to be the final outcome 
prediction. 
 
Figure 4.4.1 Flow of proposed rule selection process  
The process selects rules based on the rankings of confidence and causality values of all generat-
ed rules based on personalized clinical conditions. 
	  
4.4.3 Prediction Calibration 
 After the generation of case list with rules based on a patient’s conditions, the rule selec-
tion process outputs estimated probability that the target outcome will occur (e.g., the patient has 
an 8% chance of having ICU mortality given her risk factors). In this context, we measure the 
calibration of the estimated prediction by checking how close this prediction is to the true proba-
bility of the outcome for that particular patient. If the prediction is close to the true probability, 
then the individualized estimate is considered ‘well calibrated.’ Calibration is important for these 
types of personalized clinical decision support tools, since outcome predictions are often used to 
determine a patient’s individual risk [117-119]. 
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 A common measure of prediction calibration is Hosmer and Lemeshow’s (HL)goodness-
of-fit X2-statistic, which compares observed and predicted outcomes over groups of risk. The HL 
test specifically identifies subgroups as the deciles of fitted risk values. Specifically, the predicted 
values are arrayed from lowest to highest, and then separated into several groups of approximate-
ly equal size. For each group, we calculate the observed number of outcomes and non-outcomes, 
as well as the expected number of outcomes and non-outcomes. The expected number of out-
comes is just the sum of the predicted probabilities over the individuals in the group. And the ex-
pected number of non-outcomes is the group size minus the expected number of outcome. Models 
are called well calibrated if expected and observed event rates in subgroups are similar. Therefore, 
the HL test statistic is given by: 
  
where Oj, Ej, nj, and denote the observed events, expected events, and observations for the jth 
group, and K is the number of groups. Pearson’s chi-square is then applied to compare observed 
counts with expected counts. The HL statistic asymptotically follows a X2 distribution with K − 2 
degrees of freedom (dof). The number of groups may be adjusted depending on how many fitted 
risks are determined by the model, which is important to avoid group with singular risks. The fi-
nal calibrations can be determined based on the p-values that can be transformed from the the HL 
statistic. As with the classic good-of-fitness tests, high p-values suggest rejection of the model, 
meaning the model is well calibrated.  
4.5 Case Study 
4.5.1 Background 
 Developing risk prediction models is one of the major purposes of ICU data mining [21]. 
Models with significant validations and refinements became widely used illness scoring systems, 
such as Acute Physiology and Chronic Health Evaluation (APACHE) [22], Mortality Prediction 
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Model (MPM) [120], Simplified Acute Physiology Score (SAPS) [23], Multiple Organ Dysfunc-
tion Score (MODS) [121], Sequential Organ Failure Assessment (SOFA) [122], and Logistic Or-
gan Dysfunction Score (LODS) [123]. More recent studies applied advanced data mining ap-
proaches to develop risk prediction models that can handle more complicated clinical situations. 
For example, authors in [124] utilized fuzzy modeling and tree search feature selection to predict 
ICU readmissions; another study in [125] applied a combination of statistical models to predict 
prolonged mechanical ventilation. However, a majority of these risk prediction models share two 
common limitations—fixed attributes and fixed observation periods. 
 The development of the conventional risk prediction model started with a target clinical 
problem (e.g., mortality or prolonged ICU stay). Then researchers selected a set of attributes and 
applied feature selection methods to extract determinant ones. Finally, researchers applied ma-
chine-learning techniques to construct prediction models followed by appropriate validations. The 
goal of such process is to use as few attributes as possible to achieve a high prediction accuracy. 
However, a model with fixed variables may be applicable only to some “global” conditions (e.g., 
heart rate or blood pressure). It is challenging to adopt such models for describing individual 
characteristics that are outside the model’s conditions. Therefore, even though the model can pro-
vide evidence, the prediction still needs to be subjectively adjusted with many out-of-scope/extra 
conditions. Such a process highly relies on a clinician’s knowledge and experience, which intro-
duces uncertainty and human biases in the final decision [15].  
 In addition to the issue of fixed attributes, conventional prediction models used values 
acquired in a fixed time period. For instance, Zygun and others have used data in the first 24 
hours after admission to predict ICU mortality [35, 126, 127]. However, models with fixed obser-
vation periods may ignore the progressive nature of patient’s conditions. For example, a patient’s 
glucose level on ICU day three is likely to be different from that on the admission day but poten-
tially just as relevant. Even though several studies provide prediction models for days other than 
the day of admission, no clear discriminations were found in comparison to those only on the ad-
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mission day [38]. In addition, many models consider only the most abnormal values, which 
means a patient with five times an abnormal level is treated the same as another patient with once 
mildly elevated level. 
 Based on the two aforementioned limitations, there is a need to investigate and develop 
risk prediction models that are able to incorporate all possible conditions from a patient without 
being constrained by a specific observation period. In this case study, I expended the icuARM 
system (discussed in Chapter 2) and developed a second version of the ICU risk prediction sys-
tem, called icuARM-II, with the proposed case-based temporal association rule mining frame-
work and the new rule selection strategy using a pediatric ICU database. 
4.5.2  Database 
 After being approved by the Institutional Review Board (IRB), I imported the data in 
icuARM-II from the Children’s Healthcare of Atlanta (CHOA) pediatric ICU database. The im-
ported data contained information collected in 5,739 ICU stays from 4,975 patients aged from 
birth to 21 years old in the year of 2013. The data can be categorized into four major categories, 
including visit information, procedures, laboratory testing, and microbiology testing. Other than 
visit information, all data was collected with timestamps, which enabled the mining of temporal 
association rules. Examples and number of records in each category are tabularized in Table 4.5.1. 
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Table 4.5.1 Categories and Examples of CHOA ICU Database 
Category Measure Examples # of records 
Patient/Visit Info. 
Demographics, admission/discharge time, birth weight/length, 
discharge destination, APGAR 1, 5, 10 minutes score, ventilator 
days, financial class, PICU, NICU, CICU flags 
5,738 
Diagnoses 
Acute respiration failure, esophageal reflux, hypoxemia, unspeci-
fied asthma, with status asthmaticus, obstructive hydrocephalus, 
patent ductus arteriosus, dehydration 
59,832 
Procedures 
Oxygen supply, aerosol treatment, oxygen per shift, PH probe, 




Glucose, arterial PCO2/pH/PO2, oxygen saturation, calcium ion-
ized, HCO3, creatinine, platelet count, potassium, prolactin, salic-
ylates 
3,348,924 
Microbiology Testing Culture, specimen description, specimen source 87,843 
 
4.5.3 Method, Results, and Discussion 
4.5.3.1 Lab testing vs. six-hour ICU mortality 
 The prediction of the ICU mortality has been widely studied using conventional scales 
such as the admission-based APACHE-II [22] or the daily-based Sequential Organ Failure As-
sessment (SOFA) [122]. However, risk prediction models using laboratory (lab) testing are rela-
tively rare even though they also frequently occur in the ICU setting [128]. Developing risk pre-
diction models by including lab testing allows us to utilize hundreds of clinical attributes instead 
of a fixed number of items as in conventional scales (e.g., 12 routine physiologic measures and 
six basic scores in SOFA). Large volume of clinical attributes are fundamental for personalized 
risk prediction since they can comprehensively cover individual characteristics. Therefore, in this 
case study, I employed icuARM-II to demonstrate its ability of short-term (i.e., 6-hr) ICU mor-
tality prediction based on personalized lab testing results. 
 The lab testing dataset in CHOA ICU database consists of more than three million rec-
ords from more than one thousand tests. The case study selected the top 12 most counted tests and 
converted the numerical values into either abnormal or normal levels based on the suggested 
ranges. The total number of records in each test and those in each level are listed in Table 4.5.2. 
To predict the 6-hr ICU mortality based on personalized lab testing results, the rule was in the 
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form of A ⇒ C: {EA | TA} ⇒ {Death | <6-hr}. The antecedent episode A represents a set of ab-
normal lab testing results EA that have been observed in the last time period of TA to predict the 
Death event in the following six hours. The prediction possibility was then determined by the 
confidence values of the rules that are generated by the new proposed rule selection process. 
Since the abnormality of a lab test can occur multiple times within a observation period, we sim-
plified EA with a chain as ExN in which E was a lab testing item and N indicated its repeat. For 
instance, if a patient has had abnormal glucose level twice and abnormal creatinine level once in 
the past day, the rule was represented as {GLUx2, CREx1 | <1 day} ⇒ {Death | <6-hr}. 
Table 4.5.2 icuARM-II Case Study - Top 12 counted lab testing items in CHOA ICU 
database 
Lab Item ID 
# of Records 
Normal Abnormal Total 
Glucose GLU 19,793 38,828 58,621 
Arterial PCO2 PCO2 26,898 22,348 49,246 
Arterial pH APH 21,772 27,474 49,246 
Arterial PO2 PO2 5,733 43,513 49,246 
Ox Saturation OX 22,035 27,211 49,246 
Ionized Ca CA 28,690 14,484 43,174 
Potassium POT 24,232 16,693 40,925 
Sodium SOD 24,870 14,854 39,724 
Total CO2 CO2 42,898 6,348 49,246 
Art. Base Excess ABE 11,198 14,502 25,700 
Art. Base Deficit ABD 8,533 15,062 23,595 
Creatinine CRE 18,607 3,263 21,870 
Total 499,839 
4.5.3.2 Methods 
 To evaluate the personalized predictions of the 6-hr ICU mortality, I generated 628 rules 
with random antecedents to simulate a variety of personalized clinical conditions. Each anteced-
ent set consists of one to six types of lab abnormalities that were randomly selected from the 12 
items in Table 4.5.2. For each abnormality, the occurrence was randomly assigned from once to 
seven times.  Finally an observation window (TA) was randomly assigned to the antecedent, rang-
ing from one day to four days.  
 The flow of prediction assessment is illustrated in Figure 4.5.1. The purpose of the as-
sessment was to investigate if the newly proposed (i.e., confidence-causality-based) rule selection 
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(CC) strategy can achieve higher prediction calibration compared with the conventional top-
confidence-based rule selection, TC, i.e., the method used in CBA. I preformed 5-fold (K = 5) 
cross validation to calculate the Hosmer and Lemeshow’s (HL) X2-statistic for the prediction cal-
ibration. For each fold, the K-1 groups of data was used as the training dataset for the generation 
of the ‘estimated’ predictions using the CC and TC, which were, Pe,CC and Pe,TC, respectively. The 
remaining one group of data was used as the testing dataset for the generation of the ‘test’ predic-
tions using NRS and TCRS, which are Pt,CC and Pt,TC, respectively. Since all groups were separat-
ed with equal sizes, the total observation in each group is known. The HL-statistic and the corre-
sponding p-value (P-VCC) using CC can be calculated via Pe,CC and Pt,TC. Similarly, the HL-
statistic and the corresponding p-value (P-VTC) using TCRS can be calculated via Pe,TC and Pt,TC. 
Afterwards, the calibration performances of the two rule selection strategies can determined by 
comparing P-VCC and P-VTC. 
 
Figure 4.5.1 Flow of prediction calibration assessment 
	  
 I hypothesized that the prediction estimated by the newly proposed (i.e., confidence-
causality-based) rule selection (CC) strategy has higher prediction calibration compared with the 
conventional top-confidence-based rule selection (TC). Figure 4.5.2 shows the comparison results 
of prediction calibration using CC and TC on the 628 simulated personalized condition sets. As 
  86 
shown, 64.01% of condition sets were well calibrated by TC. Calibrations by CC were different 
with different number of selected top-ranked rules, which can reach 89.49% when the number of 
selected rule became large. Regardless of the number of selected top-ranked rules, the CC has 
statistically (p < 0.05 via Student’s t-test) and significantly better calibration than TC, which sup-
ports my hypothesis. Specifically, CC can calibrate better than TC in 90.76% of cases when the 
number of selected rule became large.  
 
                                      (a)                                                                             (b) 
Figure 4.5.2 Calibration comparison results between the newly proposed rules selection 
(CC) and the conventional top-confidence rule selection (TC). 
(a) Percentage of CC and TC that are well calibrated (i.e., p>0.05). CC with different number of 
top-ranked rules all calibrate better than TC (p<0.05 via Student’s t-test). (b) Percentage that CC 
calibrates better than TC.  
4.5.3.3 Discussion 
 It is worth noting that all of the rules generated in this case study are examples to under-
stand the influences of changes in the three aforementioned factors. Based on a patient’s instant 
conditions, clinicians can construct a personalized antecedent episode and a target consequent 
episode with flexible time windows. In addition, in this case study I only used 12 lab-testing 
items to demonstrate the rule-mining framework. The framework is actually capable of more than 
5,000 lab tests, 1,000 microbiology tests, 250 clinical procedures, and more than 40 basic infor-
mation regarding ICU visits. To provide the usability of icuARM-II, I have developed a friendly 
user interface to enable the real-world clinical decision making, which is introduced in the fol-
lowing section.  
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4.6 icuARM-II User Interface 
 The icuARM-II features a user interface that allows real-time ICU mortality prediction. 
The interface was implemented in MATLAB (MathWorks, Natick, MA). The operation starts 
from constructing new events by selecting a category, choosing a procedure and event (e.g., lab 
measures) under the category, assigning the number of repeat of the event, specifying a length of 
the observation window, and providing the target length of prediction period. The constructed 
events represent the current antecedent episode. Users can also manage the current antecedent 
episode by adding or removing events. The Run button triggers the prediction process. Based on 
the given patient episode and target mortality prediction period, the interface displays the final 
possibility with the calibration information (p-value). 
4.7 Summary and Key Innovations 
 This chapter represented an ICU decision support system, called icuARM-II, to provide 
flexible clinical risk prediction based on evidence-based and personalized temporal conditions. 
This study was an extension of my previous work (i.e., icuARM) on the ICU data mining, which 
was restricted to non-temporal clinical data, using a newly developed pediatric ICU database 
from Children’s Healthcare of Atlanta (CHOA). I first introduced a scanning strategy to generate 
temporal association rules. Then I applied fixed-outcome rule generation to produce a case list 
that contains all rules matching the patient’s clinical conditions. Given a case list, I proposed a 
case-base rule selection strategy, considering both rankings of rule confidence values and causali-
ty ratios, to improve the prediction calibration compared with conventional rule selection method. 
The proposed framework was tested using the lab testing dataset for the prediction of short-term 
(i.e., 6-hr) ICU mortality. The results shows that the newly designed rule selection strategy statis-
tically and significantly calibrates better than conventional top-confidence-based rule selection 
method. Featuring with an interactive user interface, icuARM-II has demonstrated a new solution 
for real-time and reliable risk prediction using personalized temporal clinical data. 
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 The key innovations of the work in this chapter are: 
• I provide a novel, flexible approach to temporal association rule mining by using a data 
scanning strategy, which was demonstrated to be useful in the prediction of short-term 
ICU mortality. 
• I propose a novel mining framework to combine case-based reasoning with temporal as-
sociation rules. 
• I propose a novel rule selection strategy by considering both rule confidence and causali-
ty, which has shown better prediction calibration than it by conventional top-confidence-
based rule selection strategy. 
• I present the icuARM-II system as the first application of ARM in the pediatric ICU envi-
ronment. 
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CHAPTER V 
5 PROGRESSIVE CLINICAL RISK PREDICTION 
5.1 Introduction 
  The Chapter 4 of this dissertation proposed a temporal association rule (TAR) mining 
framework for rules in the form of {EA |TA}⇒{EC |TC}. When a set of antecedent events EA have 
been observed within the past time window TA, the mining framework predicts the occurrence of 
another set of consequent events EC within the following time window TC. However, the predic-
tion time window TC in the consequent is discrete and fixed (e.g., TC = 5-hr), making rules infeasi-
ble for predictions with continuous time spans (e.g., TC = 0-hr → 10-hr). The mining framework 
can construct and integrate multiple rules with different discrete time points (e.g., 11 rules from 
TC = 0-hr → 10-hr with 1-hr step). However, such process is computationally expensive using the 
previous mining framework, and the result is still discrete. To address it, this chapter proposes a 
new mining process combining TARs with Kaplan-Meier (KM) analysis so that the prediction 
window TC can continuously span from 0 to ∞, i.e., TC = 0 → ∞. The TA constraint is also re-
moved to consider antecedent events EA observed at any time. In general, a TAR based on KM 




Therefore, whenever antecedent events EA have been observed, the rule can predict the occur-
rence of consequent events EC at any time points during the same stay.  By combining the 
Kaplan-Meier (KM) time-after-cause analysis with temporal association rules, the framework can 
determine if a pending clinical decision will potentially be a ‘cause’ of a target clinical ‘risk.’ The 
effect of a cause can be determined by comparing with two different KM-based association rules 
that have the same target risk. The framework is implemented as the third version of my ICU de-
cision support system, named icuARM-KM. This chapter is structured as follows. It first intro-
duces the mining framework that combines temporal association rules with Kaplan-Meier estima-
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tor in ICU length-of-stay and survival analyses. A strategy of handling the censoring problem in 
KM analysis is also discussed. Then the following sub-chapter provides the icuARM-KM’s user 
interface. To demonstrate the usability, I performed a case study for pediatric ICU patients with 
acute respiratory failure. The background, data, design, and results are presented and discussed. 
Afterwards, I discuss a potential improvement for the censored patient alteration strategy with 
possible solutions and challenges. The summary and key innovations are provided in the last part 
of this chapter. The work of this chapter is based on it original paper submitted to the IEEE Jour-
nal of Biomedical and Health Informatics (JBHI). 
5.2 Estimation of Personalized ICU Outcomes 
5.2.1  Personalized ICU Outcome Estimation 
 In ICU, given a patient’s basic information with existing conditions (e.g., undertaken 
procedures and current diagnoses), the goal of the mining framework is to mine rules to estimate 
how the length-of-stay (LOS) and survivability would be affected if administrating other proce-
dures of interest (POI). For instance, when a male in pediatric ICU has been diagnosed with acute 
respiratory failure and is undertaking continuous airway pressure, a clinician can refer to these 
rules to investigate how the following survivability and LOS would be affected if performing a 
blood transfusion. 
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Figure 5.2.1 Flowchart of Personalized ICU Casual Analysis 
 
 The flow of the mining process is illustrated in Figure 5.2.1. The first step is to extract all 
patients (in a group GC) who match the target patient’s basic information and existing conditions 
C. Given POI (P), the GC can be divided into two subgroups, GCP and GC!. GCP has patients satis-
fying both C and P, and GC! have patients satisfying C but not P. The medical record of each 
patient is associated with a LOS and a death flag. A LOS is a numerical value for the duration of 
the ICU stay, and a death flag is a binary value indicating if the stay ends in death (1) or not (0). 
Using these data from GCP and GC!, the process constructs two rules represented by two KM 
curves for LOS analysis: 
RCPLOS: {C, P} 
KM
 {remain  in hospital}   
RCP
LOS: {C, P} KM  {remain  in hospital}.  
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RCPLOS predicts the possibility of remaining in ICU if P is given to the patient; in contract, RCP
LOS pre-
dicts the same if P is not given. Similarly, the process constructs two more rules with two KM 
curves for survival analysis: 




SUR: {C, P} KM  {survive}  
where RCPSUR predicts the ICU survivability if P is given to the patient, and RCP
SUR
 predict the same if P 
is not given. Therefore, by comparing the two curves in each analysis, the mining process can 
determine if the POI (P) can increase or decrease the risk in terms of LOS and survivability. 
5.2.2 Alternation of Censored Lengths in KM Analysis 
 The KM analysis assumes that the target outcome will eventually occur in all subjects 
[129]. However, applying KM analysis on some ICU outcomes may violate this assumption. Take 
the case of LOS analysis that adopts survival discharge time, a patient may die and never reach a 
real survival discharge moment. Similarly, for survival analysis that uses decease time, a visit 
very likely ends in a survival discharge instead of death. A few methods have been proposed to 
deal with this sort of censoring problem. For instance, [130] disregards LOS from patients who 
die, and the study in [131] assigns the ‘worst outcome’ (i.e., the longest possible LOS) for indi-
viduals who die. However, there are no consensus in literature suggesting which way is the best 
since different methods may have different meanings, assumptions, and conclusions [132]. In the 
following of this section, I propose a new strategy to alter censored data for KM analyses of ICU 
LOS and survivability. 
 Assume si, i = 1…N, labels N ICU stays. Readmitted stays are removed so that each stay 
is associated with one unique patient. di, i = 1…N, denotes a vector of death flags in which di = 1 
indicates that the stay si ends in death, otherwise, di = 0. li, i =1…N, is a numerical array with 
lengths of these N stays. All values in li are sorted in ascending order so that li ≤ lk if i < k. If si 
ends in a survival discharge (i.e., di = 0), li is the duration from the admission time to the dis-
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charge time. In contrast, if di = 1, li is the duration from the admission time to the time of death. 
To illustrate the following process, let us consider a hypothetical data with 20 ICU stays in which 
six stays end in deaths. Their corresponding di and li are listed in Table 5.2.1. After each single 
KM analysis, the mining process can construct a KM curve with two boundaries for best and 
worst estimations, which are described in the following.  
Table 5.2.1 Example of Censor Data Alterations for ICU Length of Stay and Survival Anal-
yses Using Kaplan-Meier Estimator 
 
5.2.2.1 Length of Stay (LOS) Analysis 
 In the LOS analysis, a KM curve projects the possibility of a patient remaining in ICU for 
a certain amount of time after admission. Durations of survival stays are of interest, meaning that 
durations of deceased stays are censored since they cannot reach real survival discharge moments. 
The process uses ciLOS to indicate if a stay si is censored (i.e., deceased) in LOS analysis, which 
means ciLOS = di. Then for each stay a new array Ei can be extracted:  
Ei  = 
                            ∅                                      if  ciLOS  =  0
∀lk | k > i  &  ckLOS=  0    if  ciLOS  =  1 
. 
If a stay si is censored (i.e., ciLOS  =  1), Ei contains lengths from all non-censored stays with lengths 
longer than si. It can be hypothesized that, if a censored stay si is survival instead dead, its LOS 
can be altered according to its Ei. If Ei = ∅, the process does not alter the length since no non-
censored data can be referred to. Otherwise, the best alteration of a censored stay si can be hy-
pothesized as the minimal length in Ei since ICU LOS is the shorter the better: 
si s1 s2 s3 s4 s5 s6 s7 s8 s9 s10 s11 s12 s13 s14 s15 s16 s17 s18 s19 s20 
di 0 1 1 0 1 0 0 1 0 0 0 0 0 1 0 0 0 1 0 0 
li 10 12 13 17 21 31 43 48 51 60 77 83 94 122 141 158 162 170 190 198 
LO
S 
ciLOS 0 1 1 0 1 0 0 1 0 0 0 0 0 1 0 0 0 1 0 0 
li
LOS+ 10 17 17 17 31 31 43 51 51 60 77 83 94 141 141 158 162 190 190 198 
li
LOS,W  10 77.2 80.8 17 92.1 31 43 109.7 51 60 77 83 94 165 141 158 162 194 190 198 
li






SUR 1 0 0 1 0 1 1 0 1 1 1 1 1 0 1 1 1 0 1 1 
li
SUR+ 170 12 13 170 21 170 170 48 170 170 170 170 170 122 170 170 170 170 190 198 
li
SUR,W 28.5 12 13 38.3 21 62 63.1 48 126.1 126.8 127.3 128 128.9 122 170 170 170 170 190 198 
li
  SUR! 12 13 21 21 48 48 48 122 122 122 122 122 122 170 170 170 170 190 198 198 
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li  
  LOS+  =               li                    if    Ei
  =  ∅  
min(Ei)       if    Ei  ≠  ∅
. 
Similarly, the worst alteration can be hypothesized as 
li
  LOS!  =               li                      if    Ei
  =  ∅
  max(Ei)       if    Ei  ≠  ∅
. 
For example, the censored stay s2 has E2 = {17, 31, 43, 51, 60, 77, 83, 94, 141, 158, 162, 190, 198}; 
thus l2
LOS+
 = 17 and l2
  LOS!  = 198. This can be interpreted as: if the stay s2 ended up a survival dis-
charge instead of death, its hypothetical LOS would range between 17 days (the best) and 198 
days (the worst) according to other survival stays with lengths longer than s2. Following this prin-
ciple, the mining process can construct an array LLOS+ = {li
LOS+ | i = 1…N} with best hypothetical 
censoring lengths and another array LLOS! = {li
  LOS! | i = 1…N} with worst hypothetical censor-
ing lengths. 
 So far the best and the worst length alterations only consider the extreme cases in the Ei 
of a censored stay. They do not consider the effects of other lengths in the Ei. Therefore, Ei = {17, 
170}, Ei = {17, 18, 170}, and Ei = {17, 169, 170} all result in the same li
LOS+ = 17 and li
  LOS!= 
170. Therefore one more weighted alteration is proposed to considers all lengths in Ei:  
li
LOS,W = 
                                               li                                                  if    Ei  =  ∅
    
Ei - min(Ei)
N −   i
 + min(Ei)
 
      if    Ei  ≠  ∅
. 
For the censored stay s2 in the example, the corresponding l2
LOS,W =   1084
20-2
 +  17  =  77.2 days. The 
more and the longer non-censored lengths in Ei, the longer the weighted censoring length is. Af-
terwards, the framework can generate a new array LLOS,W = {li
LOS,W | i = 1…N} with weighted 
hypothetical censoring lengths. 
 Given the LLOS+, LLOS!, and LLOS,W with best, worst, and weighted alterations for cen-
sored lengths. The mining framework can generate one KM curve using the LLOS,W array with a 
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best boundary using LLOS+ and a worst boundary using LLOS!. The result using the 20-stay exam-





Figure 5.2.2 Examples of KM Curves Using Proposed Alteration Strategy  
The KM estimators with best, weighted, and worst censor data alterations for LOS analysis (a) 
and survivability analysis (b) using the hypothetical 20-stay example in Table 5.2.1.   
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5.2.2.2 Survival Analysis 
 The mining framework can also be applied the KM analysis to estimate a patient’s ICU 
survivability for a certain amount of time after admission. In the survival analysis, death time is 
of interest. Visits associated with survival discharge are censored because the real death moment 
cannot be reached. The process uses ciSUR to indicate if a stay si is censored in a survival analysis, 
i.e., ciSUR = 1 − di. Then for each stay si, an array Ei can be extracted:  
Ei  = 
                                  ∅                                      if  ciSUR  =  0
  ∀lk | k > i  &  ckSUR=  0        if  ciSUR  =  1 
. 
 The ICU survival length is the longer the better. Therefore, for a censored (i.e., survival) 
stay si, its hypothetical length to death can be derived from its Ei  for the best alteration: 
li
SUR+= 
              li                if    Ei =  ∅
max(Ei)    if   Ei ≠  ∅
, 
the worst alteration: 
li
  SUR!  =               li                if   Ei
  =  ∅  
min(Ei)    if   Ei  ≠  ∅
, 
and the weighted alteration: 
li
SUR,W = 





      if  Ei≠∅
 . 
 Then the mining framework can obtain three arrays LSUR+, LSUR!, and LSUR,W with the 
best, worst, and weighted hypothetical censored lengths. Afterwards, the framework constructs 
one KM curve using the LSUR,W array with a best boundary by LSUR+ and a worst boundary by 
LSUR!. The result of survival analysis using the 20-stay example is depicted in Figure 5.2.2(b). 
5.2.3 Statistical Comparison between Two KM Curves 
 From a KM curve KM(t), a continuous incidence function I(t) can be derived to describe 
the probability of the outcome incidence from time 0 to time t, i.e., 
I(t)  = 1 − KM(t).  
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The incidence function can be estimated by many probability distributions and the exponential 
distribution is the most common one [133]. Assuming I(t) is an exponential distribution function 
with a constant incidence parameter λ:  
I(t)  = 1 − e-λt, 
the KM(t) can be estimated by e-λt and can further simply represented by the incidence parameter 
λ. In this way, after obtaining two KM curves in the LOS analysis, we can represent the curve 
with POI by the estimated λW
LOS and the curve without POI by λWO
LOS.  
 In the LOS analysis, a high incidence parameter λ implies that the curve degrades faster 
so that patients can be discharged from ICU with shorter LOS. To measure how much more dan-
gerous it is to apply the POI compared to not applying the POI in terms of LOS, the mining 
framework defines the hazard ratio of a LOS analysis as: 
HLOS =   λWO
LOS  ∕  λW
LOS. 
HLOS > 1 (i.e.,  λW
LOS < λW/O
LOS) indicates that performing the POI is likely to result in a longer LOS 
(i.e., lower λW
LOS) compared with the same if not performing the POI.  
 Similarly, two more hazard ratios, can be obtained λW
SUR and λWO
SUR, to describe the two KM 
curves in survival analysis. In contract, in the survival analysis a high incidence parameter λ in-
fers that a patient may die faster with lower survivability. Thus the hazard ratio of a survival 




HSUR > 1 (i.e., λW
SUR > λWO
SUR) indicates that performing the POI increases the mortality (i.e., 
er  λW
SUR) compared to not performing the POI. To conclude, when considering a new POI, we 
should always pursuit HLOS < 1 and HSUR < 1, and the lower the better. Performing POI that meet 
these two criteria indicates that the POI can not only reduce the ICU LOS but also increase the 
patient’s survivability. 
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 The mining framework can further determine if the effect of POI is significant by the 
Log-Rank test. In statistics, the Log-Rank test is a hypothesis test to compare two KM curves 
from two different samples [134]. The null hypothesis of the test is that the two samples result in 
two identical KM curves and incidence functions. A p-value less than a threshold (usually < 0.05) 
rejects the null hypothesis, implying that the two KM curves are statistically different. Therefore, 
as shown in the end of workflow (Figure 5.2.1), the p-values from the Log-Rank test can further 
determine if the trends given by the two hazard ratios are statistically significant.  
5.3 System User Interface 
 The icuARM-KM system also features an interactive user interface for real-time investi-
gation of POI based on the analyses of LOS and survivability. As shown in Figure 5.3.1, the in-
terface accepts inputs for a patient’s basic information (i.e., gender, ICU type, and race), with di-
agnosed conditions, undertaken procedures, and the POI. Afterwards, the mining process gener-
ates two sets of KM curves for LOS and survival analyses. In each analysis, the blue KM curve 
represents the prediction if the POI is given, and the red one represents the same without POI. 
Users can turn on/off the plotting of censored data, estimated curves, and the corresponding 
best/worst boundaries. The interface also provides statistics results including (1) total numbers of 
stays in the groups with and without POI, (2) averaged LOS and survival lengths (in days), (3) the 
p-values via the Log-Rank test, (4) the hazard ratio for each analysis, and (5) the final total hazard 
ratio. The efficiency of mining process depends on the computation power of the running PC and 
can be expedited by parallel computing.  
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Figure 5.3.1 icuARM-KM User Interface 
A clinician can input a patient’s basic information (panel A) including gender, ICU type, and race. 
Diagnosed conditions and undertaken procedures are provided in panel B and C. Procedures-of-
interest (POI) panel (D) receives pending procedures. The Run button in panel E triggers the min-
ing process and the generated curves are displayed in panel F for LOS analysis and panel G for 
survival analysis. Users can switch on/off the display of censored data (+), estimation curve 
(dashed line), and the best/worst estimations (shaded area) via the check boxes in the Control 
panel E. Finally, statistical results of the curve comparison in the two analyses are displayed in 
panel H. 
5.4 Case Study in Pediatric Acute Respiratory Failure 
5.4.1 Background  
 Patients in intensive care units require frequent and dedicated monitoring of their im-
paired vital functions. The main task of ICU clinicians is to provide appropriate and continuous 
care until the patient is able to resume these functions with less support. Advanced information 
technologies in the modern ICU promise the massive influx of clinical or person-centered data, 
which grants clinicians the possibility to provide a more individualized clinical decision. Howev-
er, due to the limitations of human intellectual abilities [16] and conventional statistical analysis 
[17],  it is very challenging to transform such voluminous, complex, and biased, clinical data into 
patient-specific decisions; particularly in the time-sensitive manner often indicated. Even in the 
current era of Big Data, the actual extracted actionable knowledge remains limited. This incentiv-
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izes the need of computerized data mining techniques to realize a truly personalized care [18]. As 
resources continue to be limited, the ability to rationalize allocation of ICU resources is also a 
key-driving factor for prediction models. 
 Clinical risk prediction is one of the quintessential activities in intensive care. Risk pre-
diction or illness scoring scales are commonly used in routine ICU settings [21], including Acute 
Physiology and Chronic Health Evaluation (APACHE) [135], Simplified Acute Physiology Score 
(SAPS) [23], Sequential Organ Failure Assessment (SOFA) [136], Mortality Prediction Model 
(MPM) [120], Multiple Organ Dysfunction Score (MODS) [121], and Logistic Organ Dysfunc-
tion Score (LODS) [123].  Despite being treated as important scales in ICU risk prediction, three 
common challenges make these conventional scales limited for personalized risk prediction with 
information collected in Big Data era [24]. 
 Firstly, conventional scales calculate scores via a set of fixed variables that can only ap-
ply for pre-determined “global” conditions. For instance, the APACHE-III model consists of 
basic patient demographics, chronic health status, and 17 physiologic variables for the abnormali-
ty in vital signs, laboratory tests, and neurological conditions. These 17 variables are hard to rep-
resent hundreds of true patient conditions via data that modern bedside monitoring technologies 
are actually capturing. Clinicians can only refer to the estimated risk score and adjust the final 
prognostication with many out-of-model conditions. The final decision still relies not only on a 
clinician’s empirical knowledge and experience but also on the unspoken subjective human biases 
with inherent uncertainty [15].   
 Secondly, in addition to fixed global attributes, a conventional scale provides a score as 
an overall risk indicator for the entire clinical encounter based on a single time point. For exam-
ple, the study in [36] uses the APACHE-III scale to generate a score for the prediction of final 
mortality. Similarly, the Pediatric Index of Mortality (PIM) score predicts a pediatric patient’s 
overall likelihood of mortality based on data captured in the first few hours of their admission to 
the ICU [37].  However, an “admission” score may not account for the changes in mortality that 
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may be manifest in a progressively temporal manner or at different time points. Thus it is difficult 
to adopt an APACHE-III score to assess a patient’s mortality specifically at 48-hr, 72-hr, or any 
time point after the admission. Even though a clinician knows the patient might have a high over-
all mortality, s/he may not be able to know when that specific time point is at which their clinical 
condition will deteriorate. For this reason, there is a need for a flexible tool that can provide con-
tinuous risk prediction at any time of interest.  
 Thirdly, conventional predictive models have been developed and validated on a targeted 
cohort-based dataset. For example, all of the aforementioned risk prediction scores are adult-
specific (e.g., APACHE I-III>16 yrs old, SAPS-II >18 yrs old, and MPM>18 yrs old), except for 
PIM. Applying the model to a patient who is not similar to the original cohort may sacrifice the 
accuracy of the prediction and deviate from the original design of the model. In the most glaring 
example, adult-based scales prevent their direct application to the spectrum of pediatric ICU 
(PICU) and neonatal ICU (NICU). A few pediatric-based scales have been developed and evalu-
ated, such as the Pediatric Risk Mortality (PRISM) III [137] and PIM, but their availability is rel-
atively rare when compared to the adult-based scales. 
 In this case study, I used icuARM-KM to address the challenges of conventional ICU risk 
prediction scales that exist with fixed variables, non-temporal prediction, and specific cohort. The 
data used in icuARM-KM consists of information from more than five thousands ICU visits in 
Children’s Healthcare of Atlanta (CHOA). By using a unique data set, this case study aims to 
demonstrate that icuARM-KM can be applied in other clinical realms, using individual institu-
tional datasets – thus making this model scalable. 
5.4.2 CHOA ICU Dataset 
 As the data used in the case study of icuARM-II (Chapter 4), the data used in icuARM-
KM was imported from the EHR system in the CHOA ICU after being approved by the Institu-
tional Review Board (IRB) of both CHOA and Georgia Institute of Technology. The data consists 
of administrative and clinical information from 5,739 ICU visits in a one-year period of 2013, 
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relating to 4,975 patients aged from newborn to 21 years old. The imported ICU data can be cate-
gorized into five main types, including patient/visit information, diagnosis, procedures, laboratory 
testing results, and microbiology testing results. A randomly generated ID was assigned to each 
stay to ensure that no personally identifiable information can be traced back. The unique ID is 
also a key to link the information among all different categories.  
5.4.3 Selection of ICU Procedure 
 In the year of 2013, the CHOA ICU administrated 59,832 diagnosis records from 5,739 
stays. Acute respiratory failure (ARF) was diagnosed 2,356 times, which was the most frequent 
among all 2,901 diagnoses. In this case study, I employed icuARM-KM to demonstrate its usabil-
ity for patients with ARF. When a patient has been diagnosed with ARF and has undertaken one 
existing procedure (PROCexisting), the aim was to detect if another POI will significantly increase 
the risk (i.e., is more dangerous) in terms of both LOS and survivability.  
 This case study focused on procedures that increase adverse outcomes, instead of seeking 
a POI that would be considered “safe.” It is assumed that the procedures being performed are 
done for necessity and it is easier to link harm to a procedure. Inherently, all procedures carry 
certain elements of risk, and no procedure can really be called “safe.” There may be certain pro-
cedures that are safer than others but it is hard to make direct comparisons without knowing the 
full context. For example, the procedure may have been chosen based on clinically necessity, and 
even though a safer procedure may be available, it may not be appropriate. On the other hand, 
looking at “dangerous” POI may offer some insight to determine a patient’s clinical risk and what 
treatment patterns reflect its risk regarding LOS and mortality. 
 From the 2,901 different diagnoses, the system generated more than 4.2 million (i.e., 
C2
2901) one-to-one pairs of PROCexisting and POI. There are 650,310 pairs associated with at least 
one stay. In each pair, the first procedure was assigned as PROCexisting and the second one as POI. 
Then for each pair the system generated two rules represented by KM curves for LOS anslysis: 
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RCPLOS: {ARF, PROCexisting, POI}
KM
{remain in hospital}  
RCP
LOS: {ARF, PROCexisting, POI}
KM {remain  in hospital}  
and two rules for survival analysis: 




SUR: {ARF, PROCexisting, POI}
KM {survive}  
where POI indicates that the POI is not given.  
 To ensure the KM analysis has sufficient non-censored data, the study first removed pairs 
in which more than 90% of data was censored. I further extracted pairs that have p-values less 
than 0.05 via the Log-Rank test and the LOS hazard ratio (HLOS) and survival hazard ratio (HSUR) 
both > 2, which ensured that performing the POI may significantly cause at least twice more risk 
than not performing it. To assess an overall hazard, a final hazard ratio was calculated as HTotal = 
HLOS ×  HSUR. Following these criteria, the study finally obtained 31 pairs, which are sorted by 
their final hazard ratios with top 10 listed in Table 5.4.1. 
Table 5.4.1 icuARM-KM Use Case - Top Ten Procedure Pairs with Dangerous Out-
comes in Pediatric Acute Respiratory Failure 
 
 The final 31 “dangerous” pairs were examined by clinicians (i.e., two of the co-authors) 
for their clinical relevance. Taking pair #1 as an example, it results in the highest HTotal. ICU pa-
tients with the procedure “CT Head W/O Contrast” implies that they likely have had neurologic 
changes or concerns for an intracranial process, such as a stroke or a head bleed. Many CT scans 
will often be negative and not require any intervention, and hence unlikely to imply an effect on 
Pa
ir 
Procedure Name Number of Stays Length of Stay (LOS) Mortality HTotal = 
HLOS×









1 CT Head W/O Contrast Stat Platelet Pher U/ML 13 44 3.80 5.72E-03 3.08 6.71E-03 11.71 
2 Radex CH 1 View Front SVC I/P Dir. Contrast 1st Hr 28 250 4.27 4.01E-08 2.22 2.49E-03 9.46 
3 1st Hosp. Care PR D 50 MIN Arterial Pressure Monit. 19 224 3.14 6.03E-04 2.65 3.97E-03 8.32 
4 Kit Ballard Trach. Care 7FR Stat Platelet Pher. U/ML 36 81 3.69 1.24E-06 2.06 9.59E-03 7.60 
5 Ventilator Supplies  Stat Platelet Pher. U/ML 44 182 3.47 3.34E-08 2.09 2.25E-03 7.25 
6 Ventilator 1st Day Stat Platelet Pher. U/ML 39 152 3.34 4.49E-07 2.12 2.87E-03 7.10 
7 Cont. Mech. Vent. < 96 Hrs Serum Transfusion NEC 22 378 2.54 4.18E-03 2.76 5.36E-03 7.00 
8 Cont. Mech. Vent. < 96 Hrs Venous Cath. NEC 86 314 2.49 9.31E-08 2.15 4.18E-05 5.37 
9 D-dimers, QUANT Stat Platelet Pher. U/ML 34 48 2.07 4.66E-03 2.54 1.98E-03 5.26 
10 1st Hosp. Care PR D 50 Min. Venous Cath. NEC 57 186 2.23 1.78E-06 2.12 6.89E-03 4.72 
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overall mortality. However, patients with a true intracranial process, like a hemorrhage, will have 
a poorer prognosis. Treatment interventions for an intracranial hemorrhage will often include 
blood products (such as stat platelet, the POI); however, the blood products do not always work, 
and can significantly prolongs the LOS and reduces the survivability. Hence, the presence of a 
head CT alone may not imply pathology, but a head CT in the presence of blood product transfu-
sion is much more likely to predict a negative medical process. Thus, it is not surprising that this 
pair carries higher risk than other pairs. Similarly, in pair #9, D-dimers reflect when a patient's 
coagulation profile is deranged (also called Disseminated Intravascular Coagulation, DIC). This 
could be from infection, trauma, surgery, etc. Again, clinicians often use platelets to try and re-
verse it. However, it is worth noting that the following clinical outcomes are very likely worsened 
even when patients receive blood products (e.g., platelets, the POI). The same observation can 
also be applied for pairs 4, 5, and 6 that all have platelets product in POI. 
 It is worth noting that some pairs are not recognizable even within current medical 
knowledge, but the icuARM-KM system does show the potential dangerousness when consider-
ing the POI to the current procedure for pediatric patients with acute respiratory failure. For ex-
ample, the pairing of Ventilator Supplies and Stat Platelet Pheresis would imply a very poor otu-
come based on this model, but the actual interactive relationship is not clinically obvious. These 
pairs may provide new medical insight that a clinician will not necessarily appreciate at first 
glance. In addition, there are some pairs that have PROCexist and POI for the same treatment pur-
pose. However, combining two same-purpose procedures actually ends up with worse clinical 
outcomes, which is worth further investigating in future biomedical research, such as adverse 
drug-drug interactions.  
5.5 Potential Improvement of Censored ICU Length Alteration 
 In Chapter 5.2.2, I propose a strategy to alter censored ICU lengths of stay with best, 
weighted, and worst hypothetical lengths derived from lengths of other non-censored patients 
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(Figure 5.5.1-a). For example, in the survival analysis, ICU lengths from patients who deceased 
in ICU are of interest, and those who survived and were discharged are censored. Thus, for a cen-
sored (survival) patient, the analysis first extracts all non-censored (deceased) patients who stayed 
in the ICU longer than the censored patient. From ICU lengths of stay of all non-censored pa-
tients, the analysis calculates the best (longest), the worst (shortest), and the weighted lengths of 
stay to replace the original ICU length of the censored patient. Here, I assume that all non-
censored patients are clinically similar with the censored patient based on a user specified prima-
ry diagnoses and existing clinical procedures.  However, comparing a patient who dies in the ICU 
to a patient who was discharged after 60 ICU days may not be optimal.  Another patient who was 
discharged after ten ICU days may be more similar to a censored patient who died on the 7th ICU 
day. Therefore, analyzing historical clinical records of non-censored patients to find those who 
were clinically similar to a target censored patient could help us improve the accuracy of any data 
alteration and the subsequent survival and length of stay analyses.    
                                                
(a)       (b) 
Figure 5.5.1 ICU Length Alteration Strategies for Censored Patients 
(a) The current censored length alteration strategy and (b) a potential improvement with patient 
matching analysis to extract clinically similar non-censored patients given a censored patient 
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 In the future, a sophisticated approach should be developed to identify similar non-
censored patients given a targeted censored patient, based on their temporal clinical data (Figure 
5.5.1-b). First, a set of clinical predictors, which are generally crucial for ICU prognosis, should 
be defined to calculate a linear or nonlinear similarity between two patients. The similarity, i.e., 
the ‘distance’, data of each pair can be used to learn and evaluate algorithms in extracting clini-
cally similar patients given a specific patient. For example, Support Vector Machine (SVM) [138], 
derived from the statistical learning theory, is a linear weighted combination of symmetric kernels. 
The input of the kernels consists of the predictors of interest, while the output is a dichotomous or 
scalar outcome estimate with respect to the features of interest. Because of strong theoretical 
foundations and excellent empirical success, SVM can be used to combine the above mentioned 
similarity measures with statistical learning and then form a model for classifying the patient 
pairs into “similar” or “dissimilar” classes.  
 Patient similarity analysis is widely identified, but rarely studied. Supervised learning is 
one of the common approaches to construct patient similarity models, which means that we 
should leverage physician knowledge as input to train the similarity models. For example, the 
study in [139] describes an interactive metric learning (iMet) method that can incrementally up-
date an existing metric based on physician feedback via an online interface. Given multiple simi-
larity measures from multiple physicians, the authors present a Composite Distance Integration 
(Comdi) method that first extracts discriminative neighborhoods from each individual metric, 
then integrates measures into a single optimal distance metric.  
 After constructing and evaluating the similarity model, all similarity records of patient 
pairs can be created and stored for future LOS and survival analyses. When a patient is censored, 
our temporal mining framework alters his/her ICU length with the best, weighted, and the worst 
hypothetical lengths derived from the group of ‘clinically similar’ patients to this patient. Such a 
case-based reasoning approach will make the current icuARM-KM system more reliable by con-
  107 
sidering patient similarity based on patient-oriented clinical conditions, another step toward per-
sonalized medicine. 
5.6 Summary and Key Innovations 
 This chapter presented the development of a new personalized clinical decision support 
system, called icuARM-KM, to assist the selection of ICU procedures by evaluating its potential 
change in length of stay and survivability. The mining framework combined temporal association 
rule with the Kaplan-Meier estimator for progressive and continuous prediction, which is an im-
provement of my previous work with discrete and fixed prediction time window. I proposed a 
new alteration mechanism for censored data in ICU risk analysis and combined curve estimation 
and the Log-Rank test for statistical curve comparison. I tested the icuARM-KM system by dis-
covering dangerous procedure combinations for pediatric ICU patients with acute respiratory 
failure. After being evaluated by ICU clinicians, the results of a case study could not only verify 
current medical knowledge in procedure selection, but also uncover dangerous procedure interac-
tions even though they are performed together on a daily basis. These previously unknown 
knowledge can offer new references for clinical practice and set a new cornerstone in future bio-
medical research. 
 The key innovations of the work in this chapter are: 
• I propose the first combination of time-after-cause (Kaplan-Meier) analysis with temporal 
association rules.  
• I present icuARM-KM, the first proposed system for personalized ICU length-of-stay and 
survival analysis. 
• I propose a new solution for the censoring problem that is common in KM analysis.  
• I propose a new survival curve comparison strategy that can perform casual analysis 
when determining the risk of potential clinical procedures. I demonstrate it in a case 
study of pediatric ICU patients with acute respiratory failure.  




 The concrete goals of this dissertation were to define and demonstrate key technology 
components that facilitate evidence-based and personalized clinical decision support. The con-
crete technical and clinical achievements proposed for the four research objectives are: 
1. Development of systems using association rule mining that can mine rule-based 
knowledge for evidence-based and personalized decision support with the usability 
demonstrated in a variety of clinical settings, including pediatric neuropsychology (i.e., 
neuroARM), predictive health (i.e., PHARM), and the intensive care unit (icuARM). 
2. Development of a new association rule visualization (i.e., InterVisAR) that enables accu-
rate and effective search of personalized clinical knowledge, and provides an interactive 
graphical user interface for real-time clinical usage, which was demonstrated in all sys-
tems in this dissertation.  
3. Extension from conventional non-temporal to temporal association rule mining (i.e., 
icuARM-II) that can flexibly consider chronological relationships among clinical events, 
and utilization of case-based reasoning to assess the quality of generated temporal associ-
ation rules.  
4. Combining temporal association rules with causal and time-after-cause analyses for pro-
gressive and continuous clinical risk assessment without any prediction time constraint 
(i.e., icuARM-KM), and proposing a new solution for the censoring problem that is 
common but unsolved in current time-after-cause analysis. 
6.1 Concrete Innovation Deliverables  
 The key innovative technical methodologies and medical applications in this dissertation 
are summarized as follows: 
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• (Chapter 2) I proposed two rule-based interestingness metrics, i.e., Importance and Dom-
inance, and one item-based interestingness metric, Effect, that are all novel in ARM re-
search. I used these three metrics to reveal meaningful clinical interpretations in the 
icuARM case study in the ICU setting. 
• (Chapter 2) I developed a graphical user interface for users to interactively perform the 
ARM process, which is not available in other ARM systems, especially in the healthcare 
data mining area. 
• (Chapter 2) I successfully evaluated and demonstrated the proposed ARM system in three 
clinical settings: neuroARM in pediatric neuropsychology, PHARM in predictive health, 
and icuARM in intensive care. All are the first ARM system in their corresponding medi-
cal areas. 
• (Chapter 3) The work in Chapter 3 discusses and proposes a novel solution for the non-
factorial property. 
• (Chapter 3) InterVisAR is the first ARM visualization technique that is specifically de-
signed for association rule search. 
• (Chapter 3) I conducted a user study to evaluate the improvement of accuracy and effi-
ciency using InterVisAR for rule search. The use study is the first one in the development 
of new ARM visualization. 
• (Chapter 4) I provide a novel, flexible approach to temporal association rule mining by 
using a data scanning strategy, which was demonstrated to be useful in the prediction of 
short-term ICU mortality. 
• (Chapter 4) I propose a novel mining framework to combine case-based reasoning with 
temporal association rules. 
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• (Chapter 4) I propose a novel rule selection strategy by considering both rule confidence 
and causality, which has shown better prediction calibration than it by conventional top-
confidence-based rule selection strategy. 
• (Chapter 4) I present the icuARM-II system as the first application of ARM in the pediat-
ric ICU environment. 
• (Chapter 5) I propose the first combination of time-after-cause (Kaplan-Meier) analysis 
with temporal association rules.  
• (Chapter 5) I present icuARM-KM, the first proposed system for personalized ICU 
length-of-stay and survival analysis. 
• (Chapter 5) I propose a new solution for the censoring problem that is common in KM 
analysis.  
• (Chapter 5) I propose a new survival curve comparison strategy that can perform casual 
analysis when determining the risk of potential clinical procedures. I demonstrate it in a 
case study of pediatric ICU patients with acute respiratory failure. 
6.2 Concrete Application and Publication Deliverables  
 The key application and publication deliverables are summarized as follows with their 
corresponding innovations. 
neuroARM 
 neuroARM is a data analysis system designed for the investigation of associations be-
tween possible factors of neurobehavioral and motor disorders using a small-scale clinical data-
base of 155 children diagnosed with cerebral palsy (CP). In the case study, the system generated 
22 rules that can predict negative outcomes. These rules reinforced the growing body of literature 
supporting a link between CP, executive dysfunction, and subsequent neurobehavioral problems. 
The antecedents and consequents of some association rules were single factors, while other statis-
tical associations were interactions of factor combinations. The system was developed with the 
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Department of Neuropsychology, Children’s Healthcare of Atlanta. neuroARM is the first system 
that uses association rule mining for personalized clinical decision support in pediatric neuropsy-
chological research. The details of the system were described in Chapter 2.5.1 and in my original 
publication in the Proceedings of 2013 IEEE International Conference on Healthcare Informatics 
(ICHI) [42]. 
PHARM 
 PHARM is an interactive decision support system that was developed in conjunction with 
the Emory Center for Health Discovery and Well Being (CHDWB®). PHARM adopts association 
rule mining to generate quantitative and objective rules for health assessment and prediction. A 
case study resulted in 12 rules that can predict mental illness based on five psychological factors. 
These rules show the value and usability of the decision support system to reduce the risk of de-
veloping potential illness and to prioritize advice and action plans for reducing disease risks. To 
my knowledge, PHARM is the first decision support system for predictive health (e.g. one in 
which the mined rules are for disease prediction in a healthy population). The details of the sys-
tem were described in Chapter 2.5.2 and in my original publication in the Proceedings of 2014 
International Conference on Health Informatics [43]. 
InterVisAR 
 InterVisAR is a novel, interactive association rule visualization technique to address limi-
tations of conventional rule visualizations that only provide a global overview of rules instead of 
searching for specific rules. I conducted a user study with 24 participants, and the results demon-
strated that InterVisAR provides an efficient and accurate visualization solution for rule search. 
The results verified that InterVisAR satisfies a non-factorial property that should be guaranteed in 
the rule searching process. Participants also expressed high preference towards InterVisAR as it 
provides a more intuitive visualization environment in rule search. The user study was also the 
first designed to evaluate the performance of a new association rule visualization. The details of 
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the system were described in Chapter 3 and have been submitted to IEEE Transactions on Visual-
ization and Computer Graphics (TVCG). 
icuARM 
 icuARM is an ICU clinical decision support system using association rule mining and a 
publicly available research database, called MIMIC-II (Multiparameter Intelligent Monitoring in 
Intensive Care, 2nd version), that consists of more than 40,000 ICU stay records of more than 
30,000 patients. Under the direct guidance of ICU clinicians, the system adopted five association 
rule metrics to report associations among various clinical data. icuARM features a user-friendly 
interface that enables real-time mining of clinical data in the ICU setting.  Utilizing icuARM, I 
have investigated the associations between prolonged ICU stay and patient factors such as de-
mographics and pre-existing comorbidities. icuARM is the first personalized clinical decision 
support system for the ICU setting. I also developed three new association rule metrics – im-
portance, dominance, and effect – for different clinical knowledge interpretations. The details of 
the system were described in Chapter 2 and in my original publication in the IEEE Journal of 
Translational Engineering in Health and Medicine (JTEHM) [44]. 
icuARM-II 
 icuARM-II, the second version of icuARM, is a novel ICU risk prediction system using a 
large-scale pediatric ICU database from Children’s Healthcare of Atlanta. This new database con-
tains clinical data collected in 5,739 ICU visits from 4,975 patients. icuARM-II is built upon a 
temporal association rule-mining framework, providing a potential to predict risks based on all 
available clinical events without being restricted by fixed observation time windows. I also pro-
posed a case-base rule selection strategy, considering both rankings of rule confidence values and 
causality ratios, to improve the prediction calibration compared with conventional rule selection 
method. In addition, icuARM-II features an interactive user interface. The case study of icuARM-
II evaluated the usability of short-term mortality prediction based on clinical testing results. The 
results demonstrated a potential for reliable ICU risk prediction using personalized clinical data in 
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a previously neglected population. icuARM-II is the first ICU clinical decision support system 
that has the ability of flexible and personalized temporal knowledge discovery. The use case is 
also the first study that investigated the effect of ICU lab testing results, which shows the poten-
tial to assist ICU clinicians in selecting appropriate lab tests to reduce ICU risks, such as short-
term mortality. The details of the system were described in Chapter 4 and can be referred in my 
original publication in the Proceedings of the 5th ACM Conference on Bioinformatics, 
Computational Biology (ACM-BCB), and Health Informatics [104]. 
icuARM-KM 
 icuARM-KM is an extension in a completely new direction as compared to the prior ver-
sion, icuARM-II. icuARM-KM was developed using a large-scale pediatric database from Chil-
dren’s Healthcare of Atlanta. It uses temporal association rules to represent personalized condi-
tions and Kaplan-Meier analysis in ICU clinical decision support by evaluating their potential 
effects on length of stay and survivability. The framework includes a new strategy to address the 
censoring data problem of Kaplan-Meier models in ICU risk analysis. icuARM-KM also features 
a real-time interactive user interface. In a case study of pediatric acute respiratory failure the sys-
tem demonstrated its usefulness by uncovering previously unknown dangerous combinations of 
clinical procedures. After verification by clinicians, the results demonstrate that icuARM-KM can 
not only affirm known medical knowledge but also introduce potentially meaningful insights for 
clinical practice and future biomedical research. The details of the system were described in 
Chapter 5 and the work was submitted to IEEE Journal of Biomedical and Health Informatics (J-
BHI).  
 These systems were developed to address one or more main specific aims in this disserta-
tion. Table 6.2.1 tabulates names, research objectives, clinical settings, innovations, and the cor-
responding publications for each of the systems.  
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Table 6.2.1. Names, Research Components, Clinical Settings, Innovations, and Cor-







Setting Data Size Key Innovation 
Publi-
cation* 





Personalized ARM-based CDSS in pediat-
ric neuropsychology research C-3, J-2 
PHARM 1, 2 Predictive Health 
696 Healthy 
Subjects 
Personalized ARM-based CDSS in predic-
tive health research C-2, J-2 




Personalized ARM-based CDSS in adult 
ICU research J-1, J-2 
InterVisAR 2 Predictive 696 Healthy Subjects 
• Visualization for the search of associa-
tion rules 
• Study discussed and addressed the facto-
rial property of conventional association 
rule visualization 
• User study conducted for the evaluation 
of a newly-developed AR visualization 
JP-1 




• Data mining framework with scanning 
mechanism for flexible temporal associa-
tion rules 
• New rule selection to provide better cali-
brated clinical risk prediction 
C-1 




• Combining time-after-cause analysis for 
temporal association rules 
• Solution for censoring problem in KM 
analysis 
• Comparison strategy of survival curve 
for casual analysis of clinical risks 
JP-2 
†  Specific Aim 1: Personalized Decision Support;  
   Specific Aim 2: Interactive Knowledge Discovery;  
   Specific Aim 3: Temporal Knowledge Discovery;  
   Specific Aim 4: Clinical Causal Analysis 
CDSS: Clinical decision support system 
ARM: Association rule mining 
AR: Association rule 
KM: Kaplan-Meier 
*The codes in Publication column can be referred to Appendix B 
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6.3 Future Impacts and Closing Remarks  
 All of the systems in this dissertation are complete, functional and include many novel 
proposals. While these systems provide good examples with necessary assertions in clinical deci-
sion support research, the most important aspect remains the actual implementation of these novel 
techniques. Prior to mass deploying our clinical decision support systems, many important con-
siderations must be demonstrated beneficial, including clinical effectiveness, user acceptance, 
workflow integration, compatibility with legacy applications, system maturity, and upgrade avail-
ability [140]. However, proving these benefits will require substantial resource allocation to con-
duct user studies and trials, particularly in the area of real-time predictive and preventive clinical 
decision support. Before we can convince clinicians to embrace our support systems, it is reason-
able to require proof of analytical effectiveness, particularly if such analytical results are repre-
sented in current accepted healthcare standards. In the future, we should merge with standardized 
health IT guidelines and continuously evolve our systems to address the required benefits in the 
growing information overload, to facilitate a platform for integrating evidence-based knowledge 
into care delivery, and to integrate with comprehensive EHR systems instead of functioning as 
stand-alone clinical decision support systems. 
 In addition to the system adoption in clinical settings, further improvements are expected 
to be incremental in nature with promising returns on the additional time and resource investment. 
Specific incremental improvements could be made by expanding into three dimensions (perspec-
tives), including (1) target population size, (2) data multi-modality, and (3) data frequency. 
Target Population Dimension 
 I have highlighted the flexibility of my ARM-based systems in different clinical settings 
with a variety of population sizes, from small-scale pediatric neuropsychology (~100 patients) to 
large-scale adult ICU databases (~40,000 patients). We can increase the impact of this research 
by expanding the target population size. Doing so would include more comprehensive health-
related variables, without being restricted by specific of clinical and environmental conditions. 
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For example, as discussed in Chapter 2.5.2, the dataset of the PHARM system consists of 696 
healthy subjects. Most of these subjects are primarily Emory University employees living in the 
city of Atlanta. If we can incorporate data from a more heterogeneous population, even just with 
geographic expansion, this research can provide a more personalized decision support by includ-
ing more individual-specific health-related variables. For instance, we could determine the differ-
ence in the chance of developing lung cancer between two 50 year-old men, one in a rural area 
and one in an urban area. The pending collaboration with Morehouse School of Medicine is ex-
pected to help broaden the impact in this dimension by utilizing the national Medicare and Medi-
caid databases. 
Data Multi-Modality Dimension 
 Data multi-modality implies capturing different levels of data from a subject. More indi-
vidual-specific decision support can be achieved by integrating multi-modality data. Therefore, 
when the population size is limited, increasing the data multi-modality becomes more important. 
Clearly, my research has demonstrated usability in different level of data modality collected in a 
variety of formats, including neuropsychological questionnaires (e.g., IQ scores in the neuropsy-
chology study), clinical records (e.g., medication records and vital signs in the ICU study), and 
routine medical care (e.g., BMI and glucose level in the predictive health study). In the future, as 
data collection technology advances, we can further increase the impact of this study by integrat-
ing multimodal data from each individuals, expanding in two directions: -omics (e.g., genomics, 
transcriptomics, epigenomics, proteomics, and metabolomics) and personal health (e.g., mental, 
activity, social, and family). For example, care providers can apply a patient’s -omics profiles 
(e.g., information regarding the molecular dynamics and interactions) with personal health rec-
ords (e.g., long-time chronological blood pressure, heart rate, and psychological activity records) 
to determine the possibility of clinical manifestation of a congenital heart disease in the following 
five years.  
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 Studies have suggested benefits of the integration of multi-modality data in either the -
omic direction or the personal health direction [141]. However, the integration of data in both 
directions is a future challenge. The pending collaboration with Emory Center for Health Discov-
ery and Well Being (CHDWB) is expected to realize this scenario. In the future, we can quickly 
expand my current research when the integration of –omics data and personal health data be-
comes sufficient in the CHDWB dataset. 
Data Frequency Dimension 
  The research from Chapters 2 to 5 shows the progress from non-temporal clinical deci-
sion support to continuous temporal risk prediction. The data utilized ranges from one-time rec-
ords (e.g., neuropsychological scores in the cerebral palsy study), to sparsely sampled records 
(e.g., once to twice per year in the predictive health study), to highly intensive clinical records 
(e.g., bed-side nurse charting data in the ICU study). The last dimension of this dissertation’s fu-
ture impact could be broadened by using health data with a wider spectrum of sampling frequen-
cy, from chronological health records to intensive clinical physiological waveforms. Therefore, 
for example, an ICU clinician can order a treatment that not only depends on the patient’s instant 
vitals via bedside monitoring, but also on his/her daily physical activity record, family disease 
history, and mental stress level, etc. The pending collaboration with Emory Hospital and the on-
going collaboration with Children’s Health of Atlanta are expected to broaden the impact in this 
dimension by utilizing real-time physiological waveforms collected by clinical bed-site monitor-
ing devices. 
 These three dimensions of future impact are tightly interrelated. Figure 6.3.1 illustrates 
this in my vision of the future impact. These three dimensions form a research space for future 
technologies in healthcare decision support. This dissertation contributes to the research space by 
representing a significant step forward in achieving evidence-based and personalized clinical de-
cision support. Future work is expected to build on these advances to expand the idea in a larger 
domain, aiming to deliver the best possible quality and efficiency of healthcare.  
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Figure 6.3.1 Three Dimensional Research Space and Future Impacts of Dissertation 
The three dimensions of research space and future impacts of this dissertation include the Target 
Population Dimension, Data Multi-Modality Dimension, and Data Frequency Dimension. The 
three dimensions form a research space in clinical data mining, and this dissertation has demon-
strated its impact in a sub-space (gray cube). A future potential collaboration with Morehouse 
School of Medicine will increase the impact in the Target Population Dimension using a national 
Medicare and Medicaid database. In the Data Frequency Dimension, we will increase the impact 
by importing the ICU bedside monitoring data from ICU databases of Emory Hospital and 
CHOA. In the Data Multi-Modality Dimension, the future impact will be realized by integrating 
EHR (from ICU of CHOA and Emory Hospital), PHR and home-based monitoring (with UCSF) 
with molecular level personalized health profile (with Predictive Health Center and Emory Hospi-
tal). 
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APPENDICES  
Appendix A - Relevant Publications Composing This Dissertation 
In Preparation/Submitted 
 (JP-1) Cheng C and Wang MD. “InterVisAR: An Interactive Visualization for Associa-
tion Rule Search,” IEEE Transactions on Visualization and Computer Graphics (TVCG), submit-
ted.   
 (JP-2) Cheng C, Chanani N, Maher K, and Wang MD. “icuARM-KM: Combining Per-
sonalized Temporal Association Rules with Kaplan-Meier Estimator for Pediatric ICU Decision 
Support.” IEEE Journal of Biomedical and Health Informatics (JBHI), submitted.  
 (JP-3) Cheng C, Brown C, Stokes TH, and Wang MD. “Towards an Effective Patient 
Health Engagement System Using Cloud-Based Text Messaging Technology,” Journal of Pediat-
rics, submitted.	  
Journal/Book Publications 
 (J-1) Cheng C, Chanani N, Venugopalan J, Maher K, and Wang MD. “icuARM – An 
ICU clinical decision support system using association rule mining.” IEEE J Trans Eng Health 
Med. 2013 Nov 21; 1: 4400110.  
 (J-2) Cheng C and Wang MD. “Healthcare data mining, association rule mining, and 
applications.” In: Xu D, Wang MD, Zhou F, Cai Y, editors. Health Informatics Data Analysis: 
Methods and Examples. Springer; 2014. In Press. 
 (J-3) Phan JH, Quo CF, Cheng C, and Wang MD. “Multiscale integration of molecular, 
imaging, and clinical data in biomedical informatics.” IEEE Rev Biomed Eng. 2012 Dec 10; 5: 
74-87. 
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Conference Proceedings  
 (C-1) Cheng C, Chanani N, Maher K, and Wang MD.  "icuARM-II: improving the 
reliability of personalized risk prediction in pediatric intensive care units," in Proceedings of the 
5th ACM Conference on Bioinformatics, Computational Biology, and Health Informatics, 2014, 
pp. 211-219. 
 (C-2) Cheng C, Martin GS, Wu PY, and Wang MD. “PHARM - Association Rule Min-
ing for Predictive Health." IFMBE International Conference on Health Informatics, IFMBE-
ICHI. Vilamoura, Portugal. 2013 Nov 7; 42: 114-7. 
 (C-3) Cheng C, Burns T, and Wang MD. “Mining association rules for neurobehavioral 
and motor disorders in children diagnosed with cerebral palsy.” IEEE Int Conf Healthcare In-
form, ICHI. Philadelphia, PA, USA. 2013 Sep 9; 258-63. 
 (C-4) Cheng C, Brown C, Cohen L, Venugopalan J, Stokes TH, and Wang MD. “iACT - 
An interactive mHealth monitoring system to enhance psychotherapy for adolescencets with sick-
le cell disease.” Proceeding of Conf Proc IEEE Eng Med Biol Soc, EMBC. Osaka, Japan. 2013 
Jul 3; 2279-81. 
 (C-5) Cheng C, Brown C, New T, Stokes TH, Dampier C, and Wang MD. “SickleRE-
MOTE: A two-way text messaging system for pediatric sickle cell disease patients.” Proceeding 
of Conf Proc IEEE EMBS Biomed Health Inform, BHI. Shenzhen, China. 2012 Jan 5; 408-11. 
 (C-6) Cheng C, Stokes TH, and Wang MD. “caREMOTE: The design of a cancer report-
ing and monitoring telemedicine system for domestic care.” Proceeding of Conf Proc IEEE Eng 
Med Biol Soc, EMBC. Boston, MA, USA. 2011 Aug 30; 3168-71. 
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 (C-7) Venugopalan J, Cheng C, Stokes TH, and Wang MD. “Kinect-based rehabilitation 
system for patients with traumatic brain injury.” Proceeding of Conf Proc IEEE Eng Med Biol 
Soc, EMBC. Osaka, Japan. 2013 Jul 3; 4625-8. 
 (C-8) Venugopalan J, Brown C, Cheng C, Stokes TH, and Wang MD. “Activity and 
school attendance monitoring system for adolescents with sickle cell disease.” Proceeding of 
Conf Proc IEEE Eng Med Biol Soc, EMBC. San Diego, CA, USA. 2012 Aug 28; 2456-9. 
 (C-9) Venugopalan J, Cheng C, and Wang MD. "MotionTalk: personalized home reha-
bilitation system for assisting patients with impared mobility." Proceeding of ACM Conference 
on Bioinformatics, Computational Biology and Biomedicine, ACM-BCB. Newport Beach, CA, 
USA. 2014 Sep 20; 455-463.	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Appendix B - Glossary of Terms 
Association Rule Mining – Association rule mining is a procedure which is meant to find fre-
quent patterns, correlations, associations, or causal structures from data sets found in various 
kinds of databases such as relational databases, transactional databases, and other forms of data 
repositories. 
Data Mining – Data mining is the non-trivial extraction of implicit previously unknown and po-
tentially useful information about data.  
Case-Based Reasoning – Case-based reasoning (CBR) is a process of adapting old knowledge to 
solve new demands, using old cases to explain new situations, or interpreting new problems from 
previously reasoned procedures. 
Causal Analysis – Casual Analysis is the analysis of defects to determine their cause. Identify 
causes of defects, critical issues and other problems, plan and take action to prevent them from 
occurring in the future. Also measure the effectiveness of the actions implemented. 
Cerebral Palsy – Cerebral Palsy (CP) is a condition marked by impaired muscle coordination 
(spastic paralysis) and/or other disabilities, typically caused by damage to the brain before or at 
birth. 
Clinical Decision Support System – Clinical decision support system (CDSS) is a healthcare 
system, which is designed to assist physicians and other health professionals on decision making 
tasks. 
Health Information Technology (Health IT) - Health information technology (health IT) in-
volves the exchange of health information in an electronic environment.  Widespread use of 
health IT within the health care industry will improve the quality of health care, prevent medical 
errors, reduce health care costs, increase administrative efficiencies, decrease paperwork, and ex-
pand access to affordable health care.  
Predictive Health – Predictive Health is a transformation towards maintaining health (rather then 
treating diseases) by proactively predicting health-related events and disease development, and 
providing early and persistent interventions before being clinically overt.  
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